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Sex-based differences in innate immune responses to bacterial infection are 
evident in human patients and animal models of disease.  Females are less susceptible to 
the development of bacterial infections and subsequent bacteremia and/or sepsis while 
males exhibit a greater incidence of such infections and are more likely to devel p fatal 
sequelae.  While the precise effects and mechanisms of action remain to be determined, it 
is apparent that male and female reproductive hormones can have direct effects on the 
expression and function of key bacterial pattern recognition receptors on innate immune 
cells.  Changes in the expression of these receptors are likely to have profound effects on 
the production of the inflammatory mediators responsible for the lethal nature of septic 
shock and may underlie the observed sexual dimorphism demonstrated in immune 
responses to bacterial endotoxins.  In the present studies, we have determined the rol  of 
testosterone and estradiol on TLR4 expression from murine macrophages.  Testosterone 
suppresses both total and cell-surface TLR4 expression from macrophages, both in vitro 
and in vivo, and decreases inflammatory mediator production following LPS challenge.  
Estradiol, however, exhibits much more complicated effects on pattern recognition 
receptor expression.  Long-term exogenous estradiol treatment in vivo augments cell-
surface but not total TLR4 expression, with a corresponding increase in inflammatory 
mediator production following LPS challenge.  However, acute treatment of macrophages 
with estradiol results in an opposite effect with decreased levels of cell-surface TLR4 
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expression and inflammatory mediator production, and this effect was found to be 
mediated by the novel estrogen receptor GPR30.  As such, estrogens may be able to 
reduce the devastating inflammation associated with acute overactive host resp ns s such 
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CHAPTER ONE: INTRODUCTION 
 
 
While it has long been known that sex is a contributing factor in the incidence and 
progression of disorders associated with immune system dysregulation, it is recently 
come to light that sex also plays a role in susceptibility to infectious disease.  
Specifically, responses to bacterial infections and endotoxin differ based on sexas w ll as 
reproductive status.  In discussing sex bias to bacterial infection, it is important t  note 
that disease severity and outcome following bacterial infection are often dependant on the 
host inflammatory responses elicited by endotoxins produced by many bacterial sp cies 
(Figure 1).  Systemic inflammatory response syndrome (SIRS) describ the 
physiological changes associated with an overactive and systemic host resp nse that can 
be due to either an infectious stimuli, such as endotoxin, but can also be caused by 
physiological responses to challenges such as hemorrhage.  Patients with SIRS exhibit 
symptoms such as fever or hypothermia, tachycardia, tachypnea, and can also be 
associated with white blood cell count abnormalities (Martel 2002).  The term SIRS 
encompasses sepsis, bacteremia, and endotoxemia.  Sepsis occurs when organisms at  
local site of infection proliferate and gain access to the blood stream via tissue damage 
and/or invasion mechanisms.  Bacteremia and endotoxemia occur when bacteria or 
endotoxins such as lipopolysaccharide (LPS) are present in the blood stream, 
respectively.  LPS is a structural component of the cell wall of Gram-negativ  bacteria 
that, while not actively secreted by these organisms, is often released into the 
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extracellular milieu of the host following bacterial lysis.  The systemic circulation of 
microbes and/or endotoxin often leads to a systemic inflammatory response, and 
frequently sepsis (Figure 1).  Severe sepsis can lead to septic shock, which is categorized 
by a catastrophic drop in blood pressure that results in diminished perfusion of tissues,
hypoxia, and dysfunction of organs, including the kidneys, liver, lungs, and CNS.  This 
loss of function may lead to multiple organ failure and death (Martel 2002).  In fact, 
sepsis and the multiple organ failure associated with septic shock is the most co mon 
cause of late post-injury death in surgical intensive care units (Sauaia et al. 1995). 
Sex based differences in the immune response to bacterial infection are evident at 
multiple levels.  Both innate and adaptive immunity exhibit sexual dimorphism in human 
patients and mouse models of disease.  While disparities between men and women in B 
cell activity and antibody production in response to bacterial infection and vaccination 
are well known and are discussed elsewhere in this volume, it is also apparent that 
marked differences exist between males and females in the frequency, severity, and 
outcome of severe sepsis and septic shock.  In the following chapter, we will discuss the 
sex based differences in susceptibility to bacterial infection and discuss the mechanisms 
that may account for such sexual dimorphism. 
 
1.1  Sex based differences exist in susceptibility to bacterial infection and sepsis with 
males exhibiting higher incidence and severity 
Animal studies have provided evidence that males exhibit greater susceptibility to 
bacterial challenge than their female counterparts.  Sex based diffrences have been 
observed in susceptibility of mice to Mycobacterium marinum infection, with males 
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showing higher disease severity, bacterial burden, and mortality than infected fmale 
mice (Yamamoto et al. 1991).  Similarly, Helicobacter pylori infections in females show 
delayed onset of intestinal dysplasia relative to infected males, and show less intestinal 
inflammation and histopathology (Ohtani et al. 2007).  This difference is not limited to 
bacterial burden as animal models of endotoxemia indicate that female mice deonstrate 
higher survival rates than males when subjected to severe sepsis.  For example, 
administration of V. vulnificus derived LPS leads to endotoxic shock in male rats with a 
mortality rate of 82%.  In contrast, females treated in the same manner exhibit only 21% 
mortality following LPS challenge (Merkel et al. 2001).  Studies in mice have yielded 
similar results.  In one study, all female mice survived LPS induced sepsis, but only 70% 
of their male counterparts survived a similar treatment (Laubach et al. 1998).  In the cecal 
ligation and puncture induced model of sepsis, female mice similarly survived at a much 
higher rate (44%) relative to males (5%) (Kahlke et al. 2002).   
Findings in human patients appear to correspond with these animal studies, with 
men exhibiting greater susceptibility to bacterial infection than women.  A study of 
patients at Boston City Hospital in 1972 with bacteremia found that the incidence of 
infection was significantly higher in male patients than in females (McGowan et al. 
1975).  In addition, it has been shown that men exhibit increased mortality associated 
with nosocomial infection compared to their female counterparts (Dinkel and Lebok 
1994), and the male sex has been identified as a major risk factor for bacterial inf ction 
following severe injury with a study showing that male patients exhibit a 58% greater risk 
of developing major bacterial infections following trauma (Offner et al. 1999).   
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Again, it is apparent that these sex differences in the incidence and/or severity of 
bacterial infection are mirrored by similar differences in the development of severe sepsis 
and septic shock.  Vibrio vulnificus infection, which occurs following ingestion of raw or 
undercooked seafood, elicits endotoxic shock in humans with a fatality rate of almost 
60%, but 80% of V. vulnificus associated mortality is observed in males (Oliver 1989).  In 
addition, reviews of hospital cases have revealed that significantly fewermale patients 
were referred to the intensive care unit, and of all patients referred, men developed severe 
septic shock more frequently than women (Wichmann et al. 2000, Dosset et al. 2008).  
Women have also been found to have lower organ dysfunction scores than men following 
the development of severe sepsis (Adrie et al. 2007).  Furthermore, the outcome 
following the development of sepsis and severe sepsis also differs based between the 
sexes, with men again exhibiting greater mortality than women (Schroder et al. 1998, 
Adrie et al. 2007).   
 As such, it appears that females are less susceptible to the development of 
bacterial infections and subsequent bacteremia and/or sepsis while males exhibit greater 
incidence and severity of bacterial infections and are far more likely to develop lethal 
sequelae.  While these sex based differences have been appreciated for many years, the 
mechanisms that may account for such differences are only now becoming apparent.  It is 
conceivable that the divergence in sepsis severity could stem from differences in 
circulating endotoxin levels.  Indeed, one study has found that female rats exhibit
significantly lower endotoxin levels following cecal ligation and puncture (Erikoglu et al. 
2005).  However, this has not been a consistent observation with other groups reporting 
contradictory results (Kono et al. 2000).  A more likely mechanism for sex based 
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differences in sepsis severity lies in the relative production of key inflammatory 
cytokines that precipitate the lethal consequences of bacterial septic shock.
 
1.2  Sex based differences exist in the production of key inflammatory cytokines by 
immune sentinel cells that underlie the development of bacterial septic shock 
The development of sepsis is driven by the overproduction of cytokines including 
tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 (Blackwell and Christman 
1996).  The importance of these molecules in the development of septic shock is 
underscored by the observation that sera levels of IL-6, TNF-α, and IL-8 were 
significantly lower in sepsis patients that survived than those succumbing to this
condition (Dosset et al. 2008, Majetschak et al. 2000).  The rapid onset and progression 
of septic shock are testaments to the role played by innate immunity in the development 
of this often self destructive host response.  Macrophages can perceive bacteria and 
endotoxins to rapidly produce large amounts of these potent inflammatory cytokines.  As 
such, the lethal nature of septic shock is mediated, in large part, by the widesprea 
activation of macrophages and the subsequent overproduction of inflammatory mediators.   
Several studies have indicated that sexual dimorphism exists in the circulating 
levels of these inflammatory cytokines following infection and/or septic shock.  For 
example, male sepsis patients have been found to have higher circulating levels of TNF-α 
than female patients, and this observation correlates with a worse prognosis (Schroder et 
al. 1998).  In mice, Escherichia coli derived LPS has been found to elicit higher 
circulating levels of IL-6 in males than similarly treated female mice (Marriott et al. 
2006).  Interestingly, female sepsis patients have been found to exhibit higher levels of 
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the anti-inflammatory cytokine IL-10 than age and disease severity matched mal  
patients (Schroder et al. 1998).  While these studies appear to support the contention that 
the overproduction of inflammatory cytokines or diminished production of 
immunosuppressive cytokines correlates well with susceptibility to septic shock, it is 
important to note that some studies have failed to detect such sex based differences (May 
et al. 2008, Schroder et al. 1998), and the reason for this discrepancy is not clear. 
Importantly, there is a considerable body of work to support the hypothesis that 
sex based differences exist at the level of inflammatory cytokine producti n by isolated 
immune sentinel cells.  In vitro studies employing acutely isolated human peripheral 
monocytes and macrophages isolated from animals show male/female differnces in the 
production of inflammatory cytokines and chemokines following in vitro LPS challenge.   
For example, peripheral monocytes from male patients produce higher levels of TNF-α 
than females derived cells following LPS challenge (Asai et al. 2001, Temple et a . 2008, 
Tiberio et al. 2004) and peripheral blood cells derived from young adult men produce 
significantly more TNF-α following LPS challenge than that released by similarly treated 
cells derived from young adult women (Moxley et al. 2002).  Similarly, peritoneal 
macrophages isolated from male mice subjected to cecal ligation induced sepsis secrete 
greater amounts of TNF-α than their female derived counterparts (Kahlke et al. 2002). 
These sex based differences do not appear to be limited to TNF-α.  Male derived 
macrophages produce significantly larger amounts of the inflammatory chemokine IP-10 
than macrophages from female mice (Marriott et al. 2006).  This effect seems to be 
chemokine-specific as no sex based differences were observed in the production of MCP-
1 (Marriott et al. 2006).  In addition, in vitro studies using peritoneal macrophages show 
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that cells derived from young male mice produce higher levels of IL-1β and IL-6 
following LPS challenge than similarly treated female derived cells (Kahlke et al. 2000).  
Furthermore, peripheral blood monocytes isolated from male patients produce higher 
levels of IL-6 following LPS challenge than female derived cells (Tiberio t al. 2004).  
However, the findings for IL-6 do not appear to be as consistent as those for TNF-α and 
IL-1β as several studies have reported contradictory results.  For example, LPS 
stimulated female peripheral monocytes have been found to produce more IL-6 than male 
monocytes, even as these same cells produce less TNF-α (Asai et al. 2001).  Furthermore, 
macrophages isolated from female mice after thermal injury produce higher levels of IL-6 
upon LPS stimulation (Kovacs et al. 2002), and hypoxia stimulated IL-6 secretion was 
greater in female derived Kupffer cells, the resident macrophages of the liver (Zheng et 
al. 2006).  While these results appear to contradict the male/female differences seen in 
TNF-α production, it is important to note that interpreting changes in IL-6 levels is 
complicated by its role in the development of TH2 T-helper cell responses.  
Interestingly, sex based differences have been observed in the production of anti-
inflammatory cytokines such that female derived macrophages produce significantly 
more than that released by male derived cells.  For example, peritoneal macrophages 
isolated from male mice have been shown to produce significantly lower amounts of the 
potentially immunosuppressive prostanoid PGE2 than female derived cells (Marriott et al. 
2006).  This finding would appear to agree with previous studies showing that female 
cells can be induced to secrete more prostanoids than males (Du et al. 1984, Leslie et al. 
1987, Gregory et al. 2000a).  Furthermore, in vitro studies employing female-deriv d 
splenic macrophages have shown that these cells secrete higher levels of th  
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immunosuppressive cytokine IL-10 than male derived cells (Kahlke et al. 2000).  
However, it should be noted that some studies have failed to detect such sex based 
differences in IL-10 secretion (Asai et al. 2001, Temple et al. 2008), while one group 
found greater production of mRNA encoding IL-10 following LPS stimulation of male 
derived mononuclear cells (Temple et al. 2008).  In one study, male/female differences 
were observed in inflammatory cytokine production from mononuclear cells following 
LPS challenge, but not in IL-10 production, indicating males have proportionally less 
anti-inflammatory signals to balance the inflammatory cytokines (Tiberio et al. 2004).  
Interestingly, a study of cecal ligation and puncture induced sepsis found that exogenous 
IL-10 treatment increased male survival but had no effect on female survival (Kahlke et 
al. 2002). 
Finally, it appears that the male/female differences in LPS-induced inflammatory 
mediator production observed in monocytes/macrophages extends to other sentinel cell 
types such as neutrophils (Spitzer and Zhang 1996), and may also include non-leukocytes 
cells.  For example, LPS induced lung inflammation in male mice has been shown to be 
associated with higher levels of TNF-α than that seen in the airway fluid of female mice 
(Card et al. 2006).  Gastric tissue from male mice infected with H. pylori demonstrates 
higher expression of TNF-α than that seen in infected female tissue (Ohtani et al. 2007).  
In addition, cardiomyocytes isolated from male mice produce greater amounts of TNF-α 
following LPS challenge than do female derived cells (Zhu et al. 2009). 
As such, the majority of the data supports the idea that females can be protected 
from potentially lethal endotoxic shock in two ways: first by producing lower levels of 
the inflammatory mediators that precipitate the systemic effects associ ted with sepsis, 
9 
 
and second by elevating the production of immunosuppressive molecules that could serve 
to attenuate endotoxin-mediated systemic inflammation.  Despite the consensus that male 
and female derived immune cells appear to differentially produce inflammatory 
mediators following bacterial or endotoxin exposure, the mechanisms that underlie th se 
differences remain poorly defined.    
 
1.3  Sex based differences exist in the expression and/or functionality of receptors 
for conserved bacterial motifs 
 The recent discovery of a family of pattern-recognition receptors with a high 
degree of homology to the Toll family of proteins in Drosophila has shed light on the 
means by which innate immune cells recognize a wide range of pathogens without the 
need for prior exposure (Wright 1999, Medzhitov and Janeway 2000).  To date, at least 
eleven members of the Toll-like family of receptors (TLR) have been discovered in mice 
and humans.  These receptors detect the presence of conserved microbial motifs and 
initiate the production of cytokines, chemokines, and co-stimulatory molecule expression 
(Barton and Medzhitov 2003).   
 As shown in Figure 2, the detection of LPS involves Toll-like receptor 4 (TLR4) 
and several co-receptors and binding proteins.  LPS binding protein (LBP) is a type I 
acute phase protein that catalyses the monomerization of LPS and mediates its tran fer to 
CD14 (Schumann et al. 1990, Wright 1999).  CD14 is a co-receptor for LPS and is either 
expressed within the plasma membrane of innate immune sentinel cells such as 
macrophages or is present as a soluble molecule in the surrounding milieu.  Since neither 
CD14 nor LBP contain a cytoplasmic component, cellular responses are initiated through 
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binding with TLR4 (Poltorak et al. 1998, Chow et al. 1999, Lien et al. 2000, Akira 2006).  
TLR4 is expressed by immune sentinel cells including monocytes/macrophages and 
dendritic cells (Medzhitov et al. 1997).  However, TLR4 also exhibits a broader 
expression pattern on non-leukocytic cell types capable of inflammatory cytokine 
production including epithelial cells in a variety of tissues (Diamond et al. 2000; Kumar 
et al. 2004; Quintar et al. 2006; Hornef et al. 2002), smooth muscle cells (Quintar et al. 
2006), endothelial cells (Rock et al. 1998), and resident CNS cells such as astrocytes 
(Lewis et al. 2008).  All of these cells can therefore respond to LPS and have the 
potential to contribute to a systemic inflammatory response.  Ligation of TLR4, 
facilitated by CD14 and LBP, initiates an intracellular signaling cascade that results in the 
activation of NF-κB, a pivotal transcription factor in the regulation of inflammatory 
cytokine expression.  As such, widespread activation of cells via TLR4 can precipitat  
the overproduction of soluble immune mediators that can lead to the development of a 
systemic inflammatory response that underlies the lethal nature of septic hock (Palsson-
McDermott and O’Neill 2004). 
 Importantly, male/female differences appear to exist at the level of expression of 
these LPS receptors, and could therefore underlie the observed differences in LPS-
mediated responses in male and female-derived cells with regard to inflammatory 
mediator production.  Male mice have been found to have significantly higher circulating 
levels of LBP after LPS challenge than female mice and macrophages isolated from male 
mice express higher levels of cell surface CD14 than female-derived cells (Marriott et al. 
2006).  Interestingly, this difference appears to exist at the level of protein expression 
rather than at the level of gene transcription, as levels of mRNA encoding CD14 were not 
11 
 
significantly different between male and female derived cells (Marriott et al. 2006).  
However, it should be noted that another group has largely failed to detect such 
differences, with male peritoneal macrophages demonstrating a non-significant trend to 
express greater amounts of cell surface CD14, while splenic macrophages s owed no 
difference between male and female derived cells (Eisenmenger t al. 2004).  Temple and 
coworkers also found no sex-based difference in membrane CD14 expression on human 
mononuclear cells; however, their use of permeabolization to examine total TLR4 protein 
expression on those same cells could have had confounding effects on the measurement 
of CD14 levels (Temple et al. 2008).  
Consistent with the notion that male sentinel cells express higher levels of 
receptors for LPS than their female counterparts, macrophages isolated from male mice 
have been shown to express more TLR4 than female-derived cells (Marriott et al. 2006, 
Frisancho-Kiss et al. 2007).  Furthermore, mononuclear cells isolated from male patients 
also express significantly higher levels of total TLR4 protein than do cells from female 
patients (Temple et al. 2008, Tiberio et al. 2004).  Again, this difference appears to occur 
at the level of protein expression as expression of mRNA for this pattern recognition 
receptor was not found to significantly differ between the sexes under naive conditions 
(Marriott et al. 2006, Zhu et al. 2009).  In contrast, at least one study has reported that 
hypoxia can significantly induce TLR4 mRNA expression in male Kupffer cells, the 
resident macrophages of the liver, over that seen in female cells (Zheng et al. 2006).  
Also, following LPS challenge of murine cardiomyocytes, cells derived frommale 
animals were found to contain significantly higher levels of mRNA encoding TLR4 than 
cells from their female counterparts (Zhu et al. 2009), indicating that perhaps mRNA 
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levels can increase in male cells following challenge with infectious or endogenous 
“danger-signals”.  Finally, male peritoneal macrophages exhibit a non-significant trend to 
express more cell surface TLR4 following trauma hemorrhage than cells from imilarly 
treated females (Eisenmenger et al. 2004).  However, in this study there were no 
significant differences in such expression in naive macrophages or splenic macrophages 
following trauma hemorrhage. 
It has been suggested that sex based differences in LPS responses may also stem 
from differences in the intracellular signaling pathways initiated following TLR4 
ligation.  Specifically, hypoxia has been shown to initiate a MyD88-dependant signaling 
cascade resulting in IL-6 release from female Kupffer cells.  In contrast, male-derived 
Kupffer cells appear to rely upon a MyD88-independent signaling pathway for 
production of this cytokine (Zheng et al. 2006).  Consistent with this finding, female 
Kupffer cells demonstrated greater expression levels of the adaptor protein MyD88 than 
males (Zheng et al. 2006).  Interestingly, while Src expression levels were higher in 
female derived liver macrophages, hypoxia initiated a decrease in such expression in 
female-derived cells while eliciting an increase in Src expression in male Kuppfer cells 
(Zheng et al. 2006).  Ligation of TLR4 initiates a MAP kinase signaling and subsequent 
activation of NF-κB and female-derived peritoneal macrophages have been demonstrated 
to shown a greater degree of p38 MAP kinase phosphorylation, and hence activation, 
following LPS challenge than that found in male cells (Angele et al. 2003).  Furthermore, 
Kupffer cell NF-κB activity has been reported to be three times higher in females 
following alcohol-induced liver injury than similarly treated male-derived clls (Kono et 
al. 2000).  However, at least one study found greater ERK1/2 and p38 MAP kinase 
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phosporylation in male derived cardiomyocytes than in female derived cells following 
LPS challenge (Zhu et al. 2009). 
Taken together, evidence is accumulating that male/female differences xist at the 
level of expression of those pattern recognition receptors that can perceive bacterial 
components and can influence the signaling pathways that result in inflammatory 
cytokine production.  Because activation of TLRs and their co-receptors is responsible 
for LPS-mediated cytokine production, sex differences in these activation pathways may 
underlie the sexual dimorphism observed in immune responses during sepsis and/or 
septic shock.  While the higher expression of TLR4 and its co-receptors on male sentin l 
cells and the more efficient LPS-induced signaling pathways in female cells appear to be 
contradictory, it is important to note that TLR induces both inflammatory and 
immunosuppressive cytokine production.  As such, it is possible that the differences seen 
in female signaling pathways could result in higher anti-inflammatory cytokine 
production rather than elevated inflammatory mediator release.  Clearly, more research is 
required to validate such a hypothesis. 
 
1.4  Susceptibility to bacterial infection and sepsis differ with age and reproductive 
status 
The differences in immune responses between males and females have generally 
been assumed to be a consequence of reproductive hormones.  Circumstantial evidence 
for such a hypothesis comes from the documented differences in susceptibility to 




A study of sepsis cases in children has revealed that there are no male/female 
differences in susceptibility or mortality due to sepsis in pre-pubescent children over the 
age of one and this absence of sex based differences correlate with very low levels of 
reproductive hormones (Bindl et al. 2003).  This study did show male/female differences 
in sepsis susceptibility in neonatal infants with boys exhibiting greater sevity similar to 
that seen in adults males (Bindl et al. 2003), but it is important to note that this effect may 
well be due to the presence of residual sex hormones that are present at high levels during 
fetal development but that rapidly decrease within the first year of life.  Smilarly, sepsis 
susceptibility changes in the elderly.  While these effects may be a result of the 
physiological changes associated with aging, changes in susceptibility to bacterial 
challenge appear to be at least partially attributable to alterations in circulating levels of 
sex hormones.  In a mouse model of aging, Kahlke and co-workers (2000) found that 
peritoneal macrophages from aged mice release lower levels of the inflammatory 
cytokines IL-1β and IL-6, and greater levels of the anti-inflammatory cytokine IL-10 
upon LPS stimulation compared to young mice.  Importantly, the sexual dimorphism 
observed in cytokine production release in young mice is not apparent in aged mice 
(Kahlke et al. 2000).  Similarly in humans, elderly sepsis patients do not display 
differences between the sexes in either the incidence of septic shock or shock-a sociated 
mortality seen in younger patients (Angstwurm et al. 2005).  However, at least one 
review of hospital cases found that women had a lower risk of mortality associated with 
severe sepsis than men, but only in the above 50 years of age category (Adrie et al. 2007).  
Presumably, this would indicated that the sex difference in susceptibility to sepsis occurs 
post- and not pre-menopausal, however the authors note that low mortality and small 
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sample size in the younger than 50 category, as well as the potential of hormone 
replacement in post-menopausal women, could have confounded their results (Adrie et al. 
2007). 
Major changes in reproductive hormone production occur during female 
menopause and a growing body of evidence suggests that changes in immune cell 
populations and functions occur at this time. The ovary can function in humans from the 
teenage years through to the fifth decade of life.  However, during the perimenopause, the 
first hormonal changes occur that lead to the final menstrual period.  During 
perimenopause, circulating estrogen concentrations fluctuate greatly f om low (< 120 
pM) to high (2 µM) but do not become significantly different until close to the final 
menstrual period (Sherman and Korenman 1975, Metcalf 1988, Shideler et al. 1989).  
Postmenopause, plasma estrogen is undetectable and progesterone levels are consistently 
less than 2 nM.  Ovariectomy of mice, which models surgically induced menopause, 
results in a decreased immune response and increased mortality following bacterial 
infection.  Female mice that lack endogenous estrogen due to ovariectomy show an 
increased mortality following cecal ligation and puncture induced sepsis than age-
matched intact females (Knoferl et al. 2002).  Similarly, ovariectomized female mice 
exhibit twice the lung bacterial burden following M. avium infection than age-matched 
intact females (Tsuyuguchi et al. 2001) and mortality associated with LPS challenge is 
significantly elevated in ovariectomized female rats (Merkel et al. 2001).  Importantly, 
these effects were reversed following exogenous estrogen replacement confirming that 
the elevated bacterial burden and susceptibility to endotoxin administration are directly 
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attributable to the loss of endogenous estrogen (Tsuyuguchi et al. 2001; Merkel et al. 
2001). 
In humans, LPS sensitivity and endotoxin-associated mortality increase with age 
with postmenopausal women displaying a higher incidence of sepsis (Meyers et al. 1989, 
Beery 2003).  Peripheral monocytes isolated from post-menopausal women produced 
significantly higher levels of inflammatory cytokines following LPS challenge than 
similarly stimulated cells from pre-menopausal women (Majetschak et al. 2000, Moxley 
et al. 2004).  Majetschak and colleagues (2000) showed that post-menopausal female-
derived monocytes secreted inflammatory cytokines at the same level as male cells.  In 
contrast, one study showed that LPS-stimulated monocytes from post-menopausal 
women failed to produce comparable levels of TNF-α to those release by similarly 
challenge male-derived cells (Moxley et al. 2004).  However, it must be noted tha 
interpretation of this finding is complicated by the fact that half of the post-menopausal 
women monitored were receiving hormone replacement therapy (Moxley et al. 2004). 
Finally, normal mucosal flora has been shown to vary following menopause and 
the subsequent fall in estrogen levels.  Reductions in circulating estrogen levels corr late 
with loss of lactobacilli species in the vagina, which causes an increase in pH and 
coliform microorganisms, promoting growth of pathogenic bacteria and predisposing 
patients to infection (Gupta et al. 2006).  Hormone replacement therapy appears to 
reverse this effect and women not receiving hormone replacement therapy have greater 
incidences of E. coli and bacteroids (Gupta et al. 2006).  Such a hormone-dependent 
change in mucosal flora has important implications for the development of chronic 
inflammatory diseases and it is interesting to note that post-menopausal women receiving 
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hormone replacement therapy demonstrate a reduced incidence of inflammatory bowel 
disease (Kane and Reddy 2008). 
  As such, there is a considerable body of evidence that age and reproductive status 
can significantly influence the severity of bacterial infections and the incide e of sepsis.  
The lack of male/female differences in sepsis susceptibility in post-neonatal and pre-
pubescent children, and the increased sepsis susceptibility of post-menopausal females
that is reversed following hormone replacement, strongly indicate that reproductive 
hormones underlie the observed sex based differences in bacteremia and sepsis/septic 
shock. 
 
1.5  Sex hormones have direct effects on susceptibility to bacterial infection 
While variations in sepsis susceptibility seen with changes in age and 
reproductive status imply a role for reproductive hormones in the incidence and outcome 
of bacterial infections, more direct evidence exists that sex hormones influence acute 
immune responses to bacteria challenge.  In general, estrogen has been considered to be 
“immunoprotective.”  However, this term fails to delineate whether estrogen acts as an 
immunoenhancer to combat bacterial infection, or is an immunosuppressor and protects 
against the overactive and damaging immune response associated with sepsis.  
Testosterone, on the other hand, is widely accepted to be immunosuppressive and causes 
an increased susceptibility of both males and females to bacterial infectio .  For example, 
exogenous testosterone administration increases female mouse susceptibility to M. 
marinum infection while castration of males, and hence removal of endogenous 
testosterone, attenuates such infections (Yamamoto et al. 1991).   
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Several studies have shown that both male and female sepsis patients exhibit 
abnormally low circulating levels of testosterone (Christeff et al. 1992, Fourrier et al. 
1994) and death of males due to septic shock has been associated with extremely low 
levels of this androgen (Christeff et al. 1988).  To date, the mechanisms underlying these 
observations are not clear.  However, LPS has been reported to inhibit testosterone 
synthesis (Reddy et al. 2006) and so decreased testosterone levels could result in a more 
robust inflammatory immune response, and hence septic shock. 
It should be noted that some animal studies appear to contradict the suppressive 
effects of testosterone on sepsis-induced mortality.  In one study (Torres et al. 2005), the 
A/J mouse strain was reported to show less sepsis susceptibility following orchidectomy 
than intact males, an effect that was reversed following administration of 
dihydrotestosterone (DHT).  Furthermore, another study has reported that casr ted 
neonatal mice exhibited decreased sepsis susceptibility as adults (Bernhardt et al. 2007).  
However, a caveat of this study is that this model features the disruption of the 
hypothalamic-pituitary-gonadal axis and thereby preventing the formation of a ormal 
male brain. 
While a small number of studies have failed to show an effect of estrogen recepto  
agonists on monocyte responses to intracellular Gram-positive bacterial pathogens such 
as Listeria monocytogenes (Opal et al. 2005, Cristofaro et al. 2006), there is an 
overwhelming body of evidence indicating that estrogens, and in particular 17β-estradiol 
(E2; estradiol), are protective for bacterial infection and sepsis susceptibility.  For 
example, estrogens have been demonstrated to increase resistance to streptococcal 
infections (Nicol et al. 1964).  Estradiol administration has been found to increase 
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survival and decrease the oxidative stress along the rat gastrointestinal tract following 
intraperitoneal LPS challenge (Sener et al. 2005).  Similarly, rats treated with 
intramuscular injections of estradiol and progesterone had lower endotoxemia and 
exhibited less liver and lung congestion following cecal ligation and puncture induced 
sepsis regardless of sex, while females receiving these agents had less liver inflammation 
and less lung edema (Erikoglu et al. 2005).  Consistent with these observations, female 
rats treated with estrogen receptor agonists demonstrated lower circulating endotoxin 
levels and higher survival rates following Pseudomonas infection than untreated animals 
(Opal et al. 2005, Cristofaro et al. 2006).  Furthermore, similar treatment of male and 
female mice increased survival following cecal ligation and puncture, while an estrogen 
receptor-beta agonist, but not an estrogen receptor-alpha agonist, decreased bacteremia in 
these animals (Opal et al. 2005, Cristofaro et al. 2006).  Finally, human uterine epithelial 
cells treated with estradiol in culture have been found to have increased antibacterial 
activity following infection with S. aureus (Fahey et al. 2008). 
In addition to experiments employing the administration of exogenous estrogen or 
estrogen receptor agonists, numerous studies have assessed the role played by 
endogenous estrogen on bacterial infection outcome and sepsis.  For example, 
ovariectomy has been shown to markedly increase the severity of M. avium infection and 
this effect was reversed following estrogen replacement (Tsuyuguchi et al. 2001).  
Similarly, ovariectomy increased mortality following cecal ligation and puncture induced 
sepsis in female mice (Knoferl et al. 2002), and exacerbates H. pylori infection such that 
the severity of infection becomes comparable to that seen in males (Ohtani et al. 2007).  
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Again, this effect is reversed following exogenous estrogen treatment (Ohtani et al. 
2007). 
Removal of endogenous estrogens following ovariectomy also increases mortality 
associated with LPS challenge in rats and this effect is absent in animals that receive 
exogenous estrogen administration (Merkel et al. 2001).  In the same study, androgenized 
females that have never been exposed to endogenous estrogen or progesterone, 
demonstrate a significantly higher mortality rate following LPS challenge than sham-
androgenized females (Merkel et al. 2001).  Finally, E. coli infections in dogs are most 
prevalent during diestrus, when estrogens are at their lowest levels (Surgiura et al. 2004). 
Taken in concert, a large body of evidence suggests that estrogens are protective 
against bacterial infection and septic shock.  However, it should be noted that some data 
suggests that high estrogen levels, such as those that might be seen in late proestrus and 
early estrus, have the potential to exacerbate such infections.  For example, estradiol 
treated mice exhibit greater bacteremia and death following gonococcal infection than 
untreated animals (Kita et al. 1985).  In addition, ovariectomized mice receiving high 
dose exogenous estrogen replacement demonstrate a higher incidence of E. coli infection 
in the kidney due to urinary tract infection than untreated mice (Curran et al. 2007) 
Furthermore, acute injection of the estrogen, estriol, was found to dramatically in rease 
LPS-associated mortality in rats (Ikejima et al. 1998).  Also, estrogen lev ls have been 
found to be higher in patients that develop an acute infection (within one day) following 
traumatic injury (Gee et al. 2007).  
Finally, and perhaps more importantly, the increased incidence and severity of 
sepsis in humans correlates with sera estrone and estradiol levels.  Female patients that 
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were admitted to the intensive care unit for sepsis had 10-20 times higher levels of these 
hormones than non-sepsis patients, while male sepsis patients exhibited 3-5 times higher 
estrogen levels (Fourrier et al. 1994).  These results are in agreement with another recent 
study demonstrating that estradiol levels are significantly higher in non-surviving sepsis 
patients, regardless of sex (Dosset et al. 2008).  Furthermore, the probability of death due 
to septic shock was found to be lowest when circulating sera estradiol levels were within 
the physiological range (0.01-0.37 ng/ml in females and 0.02-0.06 ng/ml in males), but 
increases sharply when levels were beyond this range (May et al. 2008).  Interesti gly, it 
was found that while all male sepsis patients had elevated estrone and estradiol levels in 
the first two days following admission to the intensive care unit, men that subsequently 
succumbed to septic shock were found to have maintained and even elevated estrogen 
levels in contrast to sepsis survivors (Christeff et al. 1992).  Indeed, the correlati n 
between sera estrone levels and sepsis severity was such that the authors of this study 
proposed that the levels of this hormone could be a useful predictor of outcome for sepsis 
patients.  The increases in estrone and estradiol levels associated with sepsis do not 
coincide with increases in LH or FSH levels, indicating that these changes are due to 
increased synthesis of estrogens in the periphery (Fourrier et al. 1994).  Interestingly, it 
has been found that the presence of LPS and/or inflammatory cytokines can increse 
activity of aromatase, the enzyme responsible for converting androgens into estrogen  
(Schmidt et al. 2000, Singh et al. 1997).  Furthermore, it has been found that 
macrophages can actively convert androgens into the estrogen estriol (Schmidt et al. 
2000).  As such, high levels of circulating LPS and inflammatory cytokines in patients 
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with sepsis may have the ability to exacerbate symptoms by increasing production of 
estrogens. 
Taken together, these findings indicate that while testosterone tends to increase 
susceptibility to bacterial infection and estrogen generally provides protection.  However, 
it is important to note that super-physiological levels of female reproductive hormones 
may exert a contrary effect and negatively influence the outcome following sepsis.   
 
1.6  Sex hormones have direct effects on immune cell function and modulate sentinel 
cell responses to bacterial motifs 
Sexual dimorphism in acute immune responses to bacterial infections and the 
effects of reproductive hormones on susceptibility to such challenges indicate rect 
endocrine effects on the function of sentinel cells.  Such a hypothesis has been supported 
by the presence of receptors for reproductive hormones in a variety of leukocyte types. 
Macrophages have been widely demonstrated to express estrogen receptors (Olsen and 
Kovacs 1996, Angele et al. 2000) and this sex hormone can modulate macrophage 
function by normal genomic or alternative non-genomic events.  In vitro treatment with 
estradiol has been found to initiate the rapid activation of lipid secondary messeng rs, 
including phosphatidylinositol 3-kinase, in this cell type (Ghisletti et al. 2005).  While 
classical androgen receptors do not appear to be expressed by macrophages, recent 
studies suggest that these sentinel cells possess non-classical cell surface receptors for 
testosterone (Benten et al. 2004).  Treatment with this male sex hormone elicits an 
increase in intracellular calcium in macrophages and a resulting down-regulation of LPS-
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induced c-fos promoter activity, while estrogen has the opposite effect (Benten et al. 
2004). 
Since testosterone appears to suppress immune responses to bacterial challenge 
and the overproduction of cytokines underlies the lethal nature of sepsis, one might 
anticipate that androgens directly alter the secretion and production of these 
inflammatory mediators.  A considerable body of evidence has shown that male sex 
hormones suppress the responses of immune cells to endotoxin challenge.  Removal of 
endogenous testosterone following castration results in an increase in LPS-induced IL-1 
and IL-6 production by mouse peritoneal and splenic macrophages (Wichmann et al. 
1997).  In vitro treatment of murine peritoneal macrophages with testosterone decreases 
secretion of IL-1β following LPS challenge (Savita and Rai 1998), and causes a modest 
reduction in TNF-α secretion by such cells isolated from male but not female animals 
(Chao et al. 1995).  Furthermore, it has been found that in vitro DHT treatment reduces 
IL-6 expression in LPS-stimulated umbilical chord endothelial cells via androgen 
receptors (Norata et al. 2006). 
In addition to inflammatory cytokines, testosterone has been shown to attenuate 
the production of other immune molecules used to combat bacterial infections.  Notably, 
macrophages isolated from castrated male mice produce more nitric oxide (NO) upon 
LPS stimulation indicating that endogenous testosterone suppresses NO release by these 
cells.  Consistent with this conclusion, in vitro testosterone treatment results in decreased 
NO release by stimulated primary macrophages (Savita and Rai 1998) and RAW 264.7 
macrophage-like cells with both pre- and post-transcriptional effects on the expression of 
inducible nitric oxide synthase (Friedl et al. 2000).  It is clear that the immunosuppressive 
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effects of testosterone are not due to the peripheral aromatization and conversion of 
testosterone to estradiol because DHT, which is not converted to estrogen, also has 
suppressive effects and these actions are not affected by estrogen receptor inhibi ors 
(Norata et al. 2006). 
Finally, there is some evidence that the immunosuppressive actions of 
testosterone are specific to certain challenges and may be restricted based on sex.  For 
example, it has been suggested that testosterone does not depress immune function in 
healthy animals but can suppress immune responses following insults such as traum-
hemorrhage (Angele et al. 1999), and female mice treated with DHT have been 
demonstrated to have higher in vivo TNF-α responses to LPS than untreated females and 
beyond that seen in male mice (Card et al. 2006).  While the reasons for these 
discrepancies are presently unclear, it is possible that they stem from the fact that the 
suppressive effects of testosterone may be somewhat non-selective as androgens have 
also been implicated in the suppression of anti-inflammatory mediators.  Orchidectomy 
has been shown to result in increased sera IL-10 levels after LPS challenge compared to 
intact males (Torres et al. 2005) and DHT can attenuate IL-10 production by LPS 
stimulated macrophages (Angele et al. 1999).  Futhermore, orchidectomy has been shown 
to decrease inflammation due to infectious myocarditis.  This effect is mediated by an 
increased proportion of anti-inflammatory regulatory M2 macrophages in the heart, 
indicating that testosterone inhibits anti-inflammatory populations of macrophages 
(Frisancho-Kiss et al. 2009).  
Since the consensus is that testosterone is immunosuppressive and generally 
decreases inflammatory cytokine production by immune sentinel cells, one might 
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anticipate that estrogen would conversely increase the production of these mediators by 
cells such as macrophages.  Indeed, several studies would seem to support this 
hypothesis.  The production of inflammatory cytokines within the brain following 
intracerebral injection of LPS has been found to be attenuated in ovariectomized animals, 
an effect that is reversed following exogenous estrogen administration (Soucy et al. 
2005).  In addition, an intermediate dose of estradiol (0.1 ng/mL) results in a significant 
increase in TNF-α secretion by rat peritoneal macrophages stimulated with LPS (Chao et 
al. 1995), and acute in vivo estriol treatment has been shown to increase sera TNF-α 
levels and Kupffer cell TNF-α mRNA expression in rats challenged with LPS (Ikejima et 
al. 1998).  Exposure to estradiol or estriol has been shown to increase sera TNF-α levels 
in female mice following in vivo LPS challenge, an effect that was antagonized by an 
agent that can serve as an estrogen receptor antagonist (Zuckerman et al. 1995, 
Zuckerman et al. 1996).  Furthermore, treatment of isolated human peripheral monocytes 
with estradiol was found to increase TNF-α production from male derived cells (Asai et 
al. 2001), and peritoneal macrophages isolated after acute in vivo LPS treatment 
demonstrated a modest increase in the expression of mRNA encoding TNF-α after in 
vivo estriol exposure (Zuckerman et al. 1996).  Removal of endogenous estrogens 
following ovariectomy has been shown to result in dramatic reductions in LPS-induced 
elevations of TNF-α mRNA expression in the brain, an effect that is reversed following 
estradiol replacement (Soucy et al. 2005).  Finally, peripheral monocytes isolated from 
post-menopausal women with low levels of estradiol secrete significantly lower amounts 
of TNF-α following stimulation than cells isolated from pre-menopausal women 
(Verthelyi and Klinman 2000). 
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 In addition to TNF-α, there is also evidence that estrogen can augment the 
production of other inflammatory cytokines.  For example treatment of human peripheral 
monocytes with estradiol has been found to increase IL-6 production from male derived 
cells both before and after LPS stimulation (Asai et al. 2001).  Interestingly, one study 
has found that while there is no difference in maximal IL-6 production in female mice 
following estrogen treatment, females treated with estriol produced IL-6 with faster 
kinetics following LPS challenge than that seen in untreated females, and this effect was 
inhibited by an agent that can antagonize estrogen receptors (Zuckerman et al. 1996).  
Peritoneal macrophages isolated from mice exposed in vivo to estradiol have been shown 
to exhibit increased expression of mRNA encoding for IL-6, IL-1β, IL-12, and iNOS 
following LPS challenge (Calippe et al. 2008).  Furthermore, in vitro treatment of mouse 
peritoneal macrophages with estradiol has been found to increase LPS-stimulated IL-1β 
production (Savita and Rai 1998), while in vivo treatment of rodents with estradiol has 
been found to increase sera NO levels (Ikejima et al. 1998) and splenocyte production of 
IL-1α and IL-1β following in vitro restimulation (Dai et al. 2007).  Lastly, estrogen may 
promote immune responses by limiting the production of the immunosuppressive 
cytokine IL-10, as one study has shown that in vitro estrogen treated male human 
peripheral monocytes produce lower amounts of this cytokine following in vitro 
stimulation (Asai et al. 2001). 
 Having made the case for estrogens enhancing the production of inflammatory 
mediators it might be surprising to learn that the preponderance of evidence appears to 
contradict this idea.  For example, lower levels of IL-6 and TNF-α have been observed in 
the peritoneal fluid following cecal ligation and puncture in mice that were treated with 
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an estrogen receptor agonist (Cristofaro et al. 2006), and acute intraperitoneal treatment 
with estradiol attenuates LPS induced elevations in sera TNF-α levels in rats (Sener et al. 
2005).   Both low (less than 10-5 ng/mL) and high (greater than 1ng/mL) doses of 
estradiol have been shown to decrease secretion of TNF-α by LPS treated rat peritoneal 
macrophages (Chao et al. 1995).  Estradiol can decrease LPS induced TNF-α expression 
by murine macrophages (Salem et al. 2000) and human peripheral monocytes (Vlotides et 
al. 2007, Asai et al. 2001).  This effect does not appear to be limited to 
monocytes/macrophages, as gastric tissue infected by H. pylori produced more TNF-α 
following ovariectomy, an effect that was reversed by estradiol replacement (Ohtani et al. 
2007).  Furthermore, in vitro estradiol treatment of astrocytes decreased LPS induced 
TNF-α expression (Kipp et al. 2007, Lewis et al. 2008), and this decrease was inhibited 
by an estrogen receptor antagonist (Kipp et al. 2007).  Finally, a study of trauma p tients 
found that sera estradiol levels were negatively correlated with levels of TNF-α, though 
not sera levels of IL-6 or IL-8 (Gee et al. 2007). 
The effects of estrogens on IL-6 levels appear to be in agreement with the 
findings for TNF-α production in that estrogen decreases the production of this cytokine 
following bacterial challenge and/or exposure to endotoxin.  Acute in vivo exposure to 
estradiol has been found to decrease IL-6 levels following endotoxin challenge 
(Zuckerman et al. 1995) and macrophages elicited from estradiol treated mice expressed 
lower levels of mRNA encoding IL-6 than untreated mice following in vitro restimulation 
(Zuckerman et al. 1995).  In addition to immune sentinel cells, other cell types capable of 
responding to LPS have been shown to produce lower levels of IL-6 following estrogen 
treatment.  Human retinal pigment epithelial cells have been shown to have lower LPS 
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induced IL-6 responses following exposure to estradiol, and this effects has been 
demonstrated to be reversed following treatment with an estrogen receptor antagonist 
(Paimela et al. 2007).  Acute estradiol treatment has also been found to attenuate LPS 
induced IL-6 production from human uterine and endometrial epithelial cells (Lesmeister 
et al. 2005, Fahey et al. 2008) and murine astrocytes (Cerciat et al. 2009).  
In addition to TNF-α and IL-6, estrogens have been shown to decrease production 
of bacterial/endotoxin induced production of other inflammatory mediators, including IL-
1β, inflammatory chemokines, and NO.  Resident CNS cells that exert sentinel immune 
functions, including microglia and astrocytes, exhibit diminished LPS induced IL-1β 
production following exposure to estradiol or estrogen receptor agonists (Lewis et al. 
2008).  Similarly, gastric tissue from ovariectomized females infected by H. pylori has 
been found to contain higher levels of IL-1β than that seen in infected intact females, an 
effect that was reversed following estradiol replacement (Ohtani et al. 2007).  Short-term 
in vitro exposure to estradiol has also been found to decrease murine peritoneal 
macrophage expression of mRNA encoding for IL-1β, IL-12, and iNOS following LPS 
challenge, an effect contrary to what was seen due to the presence of in vivo estradiol 
(Calippe et al. 2008).  CXCL8 (IL-8) secretion attracts immune cells to the site of 
bacterial infection, and excess infiltration of leukocytes, including neutrophils, can 
contribute to the pathogenesis of sepsis.  Treatment of female human peripheral 
monocytes with estradiol results in a dose dependent decrease in LPS induced mRNA 
expression and secretion of IL-8 (Pioli et al. 2007).  Similarly, estradiol decreases 
expression of mRNA encoding another inflammatory chemokine, CXCL2 (MIP-2), in 
LPS treated macrophages (Ghisletti et al. 2005).  This effect was driven by effects on NF-
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κB function, as estradiol decreases p65 binding to the MIP-2 promoter (Ghisletti et al. 
2005).  Acute estradiol treatment has also been found to attenuate LPS induced MIP-3α 
production from uterine epithelial cells (Soboll et al. 2006).  Murine astrocytes hav  been 
shown to have decreased levels of the inflammatory chemokine IP-10 following LPS 
challenge in vitro (Cerciat et al. 2009).  The presence of in vivo estradiol has been 
reported to decrease inflammation in the brain of rats by decreasing the proportion of 
MHC class II immunoreactive microglia following LPS treatment.  However, th  dose of 
estradiol associated with this effect is dependant on sex, with only low doses decr asing 
immunoreactive microglia in male brains and only high doses of estradiol suppressing 
inflammation in female brains (Tapia-Gonzales et al. 2008).  Finally, ovariectomy results 
in the elevated production of NO by macrophages upon stimulation with LPS indicating 
that endogenous estrogen decreases NO secretion.  Consistent with this notion, in vitro 
treatment of macrophages (Savita and Rai 1998) and microglia (Vegato et al. 2000) with 
estradiol leads to diminished LPS-induced NO release, an effect reversed following 
exposure to an agent that can inhibit estrogen receptors (Savita and Rai 1998).  Also, 
treatment of macrophages with endocrine disruptors results in decreased LPS-induced 
NO production and NF-κB activation, an effect that was found to be at least in part 
mediated by the classical estrogen receptors (Yoshitake et al. 2008). 
The idea that estrogen limits inflammatory responses is further supported by its 
documented effects on the production of the immunosuppressive/anti-inflammatory 
cytokine IL-10.  For example, estradiol treatment of orchidectomized male mice 
increases IL-10 secretion from LPS stimulated Kupffer cells (Angele et al. 1999).  
Furthermore, exogenous estradiol treatment causes a significant increase in IL-10 
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production in ovariectomized mice infected with H. pylori (Ohtani et al. 2007), and long 
term in vivo treatment of male mice with estradiol was found to increase splenocyt  IL-
10 production following in vitro concanavalin A challenge (Dai et al. 2007).   
 Taken together, there appears to be a consensus that testosterone limits the 
production of key inflammatory mediators consistent with an immunosuppressive role for 
this hormone.  In contrast, the effects of estrogen appear to be far more controversial.  
While data is available to support the enhancement of immune sentinel cells responses by 
this hormone, a large body of work contradicts these findings and points to a suppressive 
action of estrogens on inflammatory cytokine and chemokine release by a number of host 
immune cell types.  While the reasons for these disparate results are unclear, it is possible 
that the effects of estrogen are dependent on the particular challenges faced by the host, 
the kinetics of the immune response, and the effective dose of estrogen.  For example, it 
is possible that while intermediate doses of estrogen enhance cytokine releas, very low 
or very high doses can have the opposite effect.  Alternatively, these often confusing 
results may again stem from the differences between immunosuppressive verus 
immunoprotective actions.  It is important to note that in order to protect an individual 
during sepsis, a decreased production of potent inflammatory cytokines such as TNF-α, 
IL-6, and IL-1 would be desirable.  Obviously, further study is necessary to clarify this 
issue. 
 
1.7  Sex hormones have direct effects on the expression of pattern recognition 
receptors and their signal transduction pathways in immune sentinel cells 
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As discussed previously, it has now become apparent that acute immune 
responses of key sentinel cells to bacterial pathogens are initiated via the recognition of 
conserved microbial motifs including LPS and bacterial lipoproteins by receptors, TLR4 
and TLR2, respectively.  In addition, the recognition of LPS is facilitated by co-receptors 
such as CD14 and molecules including LBP.  Recognition of bacterial components by 
these receptors initiate MAP kinase cascades and NF-κB activation via adaptor molecules 
including MyD88.  The activation of NF-κB will then alter gene transcription of pro- and 
anti-inflammatory cytokines precipitating the "cytokine storm" that underlies bacterial 
septic shock. 
In accordance with the inhibitory effects of androgens on cytokine production, 
testosterone has been shown to attenuate LPS-induced activation of p38 MAP kinase but 
not ERK1/2 or JNK/SAPK activation in macrophages (Benten et al. 2004), while DHT 
appears to interfere with the ability of NF-κB to bind to DNA promoters in umbilical 
cord endothelial cells (Norata et al. 2006).  Similarly, and in agreement with the 
documented ability of estrogen to limit inflammatory cytokine production, female sex 
hormones have been shown to inhibit NF-κB activity.  For example, treatment with an 
estrogen receptor agonist can cause a decrease in cellular NF-κB reporter activity (Opal 
et al. 2005) and acute estradiol treatment has been found to decrease DNA binding of NF-
κB (Paimela et al. 2007, Ghisletti et al. 2005).  It appears that estradiol can regulate NF-
κB activity at the level of nuclear translocation.  Estradiol retains p65/Rel-A and c-Rel in 
the cytoplasm of immune cells following stimulation (Ghisletti et al. 2005, Dai et al.
2007), regardless of IκBα synthesis, phosphorylation, or degradation (Ghisletti et al. 
2005), and appears to target the microtubule-associated transport system used by NF-κB 
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subunits (Ghisletti et al. 2005).  Interestingly, estradiol was not found to inhibit the 
nuclear translocation of the p50 subunit and increases the expression of Bcl-3, a protein 
that binds to p50 homodimers to permit transcription of NF-κB responsive genes (Dai et 
al. 2007).  Furthermore, estradiol has been found to affect the activation of the PI3K/Akt 
pathway, which in turn inhibits NF-κB activity and resulting inflammatory cytokine 
secretion.  While short-term in vitro treatment with estradiol enhances murine 
macrophage phosphorylation of Akt, chronic in vivo estradiol exposure results in the 
opposite phenomenon, as well as inhibition of PI3K activity, following LPS challenge of 
these cells (Calippe et al. 2008).  As such, these effects might provide several 
mechanisms underlying the seemingly paradoxical ability of estrogen to both inhibit and 
promote inflammatory gene expression. 
While reproductive hormones may have specific effects on the amount or function 
of signal transduction components, it is clear that endocrine-induced changes in the level 
of expression of pattern recognition receptors, their co-receptors, or adaptor molecules 
would have a profound influence on downstream cellular events including NF-κB 
activation and cytokine production.  Importantly, one recent study indicated that sex 
hormones can directly alter the expression of innate receptors for bacterial components as 
summarized in Figure 2.  It has been shown that rat prostate cells from orchidectomized 
animals express higher levels of TLR4 following E. coli infection compared to intact 
males but were restored to normal levels following testosterone replacement (Quintar et 
al. 2006). 
Once again, while the effects of testosterone appear to be consistent, the effects of 
estrogens on pattern recognition receptor expression are more complicated as cute 
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administration of estrogen fails to alter such expression in vitro.  For example, acute 
estrogen treatment of macrophage-like cell lines (Vegato et al. 2004, Vlotides et al. 
2007), and Kupffer cells (Ikejima et al. 1998), or LPS challenged human monocytes 
(Pioli et al. 2007), fails to significantly alter TLR4 or CD14 expression.  In contrast, a 
number of studies show that estrogen can have significant effects on pattern recognition 
receptor expression in vivo.  For example, in vivo administration of estriol can elevate 
expression of mRNA encoding CD14 and LBP in Kupffer cells (Ikejima et al. 1998), and 
ovariectomy results in markedly lower TLR2 transcription in the brain in response t LPS 
compared to that seen in intact females, an effect that can be reversed following 
exogenous estrogen replacement (Soucy et al. 2005).  One study with low sample size 
found that macrophages from estradiol treated ovariectomized mice expressed slightly,
but not significantly, higher levels of cell surface CD14 (Calippe et al. 2008).  Finally, 
expression of MyD88, an important adaptor protein in TLR signaling, was found to be 
increased following in vivo treatment of male mice with estradiol (Zheng et al. 2006).  
However, it has been found that chronic in vivo treatment of ovariectomized mice with 
estradiol fails to alter total cellular TLR4 protein content in peritoneal macrophages 
(Calippe et al. 2008).  While hormone replacement therapy has not been reported to alter 
the levels of TLR4 expression in circulating monocytes isolated from elderly post-
menopausal women undergoing exercise training (Flynn et al. 2003), it must be noted 
that the results of this study are difficult to interpret due to the physiologica effects of 
aging and exercise. 
 That being said, at least one study has shown contrary effects of estradiol on TLR 
expression.  Levels of mRNA encoding for several TLRs have been found to vary with 
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the estrous cycle in the human uterine endometrium.  Higher levels of mRNA encoding 
for TLR2, TLR3, TLR4, and TLR9 correlate with low levels of estradiol.  Furthermore, 
endometrial cells treated in vitro with estradiol for 72 hours, but not 24 or 48 hours, 
exhibited reduced expression of mRNA encoding for TLR4, but not TLR2, TLR3, or 
TLR9 (Hirata et al. 2007).  Interestingly, progesterone treatment of endometrial c lls for 
72 hours yield higher levels of mRNA encoding for TLR4, and normalized levels when 
co-treated with estradiol (Hirata et al. 2007). 
 
1.8  The novel G protein coupled receptor GPR30 binds to estradiol and elicits rapid 
cellular responses 
One explanation for the apparently contradictory actions of estrogens could be 
due to the existence of multiple types of receptors for this hormone.   Rapid signaling 
events and genomic actions of estrogen have previously been exclusively attributed to the 
actions of the classical nuclear hormone estrogen receptors, ERα and ERβ.  These 
receptors bind to estrogen intracellularly and typically translocate to the nucleus where 
they bind to estrogen response elements on DNA to activate or repress transcriptio  
(reviewed in Beato 1989).  However, the recent discovery of a non-classical membran  
estrogen receptor that also mediates rapid non-genomic events has shed light on different
actions of estrogen.  The G protein coupled receptor GPR30 is a seven transmembrane 
receptor that has very high affinity for 17β-estradiol and not other estrogens, 
progesterone, or testosterone (Thomas et al. 2008, Revankar et al. 2005).  While 
structurally unrelated to the classical estrogen receptors, overwhelming evidence has 
shown that GPR30 binds to estradiol and mediates rapid actions of this hormone.   
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Estrogen bound GPR30 has been found to initiate several rapid cellular effects 
that are not mediated by the traditional estrogen receptors.  GPR30 promotes estradiol 
activation of the MAP kinase signaling molecules ERK1 and ERK2 via the Gβγ protein 
subunit (Filardo et al. 2000).  The Gα subunit has been found to cause activation of 
adenylyl cyclase and an increase in cAMP after GPR30 binding to estradiol (Filardo et al. 
2002, Hsieh et al. 2007a).  Importantly, both of these effects were found to be estrogn 
receptor independent.  The actions of estradiol binding to GPR30 are very rapid, with an 
increase in activation of adenylyl cyclase and cAMP found within 10 to 15 minutes of 
binding (Thomas et al. 2008, Filardo et al. 2002, Filardo et al. 2007).  GPR30 has also 
been found to initiate an intracellular calcium influx (Revankar et al. 2005, Filardo et al. 
2002, Funakoshi et al. 2006, Wang et al. 2008).  Intracellular calcium is elevated by 10 
seconds after estrogen treatment, and calcium stays elevated for over 5 minutes 
(Funakoshi et al. 2008). 
Importantly, the selective estrogen receptor modulator 4-hydroxytamoxifen and 
the classical estrogen receptors ERα and ERβ antagonist ICI 182780, are both agonists 
for GPR30 (Thomas et al. 2008, Pang et al. 2008).  ICI 182780 has previously been 
considered a pure anti-estrogen because of its inhibitory effects on the nuclear hormone 
estrogen receptors.  However, recent evidence has shown that this compound is in fact an 
agonist for GPR30, mimicking the effects of estradiol (Filardo et al. 2000, Pang et l. 
2008, Teng et al. 2008, Kamanga-Sollo et al. 2008).  ICI 182780 and tamoxifen have 
competitive affinity for GPR30, at about 10% of the affinity of estradiol (Thomas et l. 
2008).  It has been found that the molecule G1 is a specific agonist for GPR30, and 
initiates activity in this receptor similar to estradiol (Pang et al. 2008, Teng et al. 2008, 
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Kamanga-Sollo et al. 2008, Kuhn et al. 2008).  G1 has no activity for the classical 
estrogen receptors, nor does it cause effects in cells lacking GPR30 (Bologa et al. 2006).  
GPR30 alone, and not the classical estrogen receptors, has been found to mediate 
important effects of estradiol in several cell types (Wang et al. 2008, Kuhn et al. 2008).  
In some cases, GPR30 has been found to work in conjunction with ERα to induce 
proliferation (Kamanga-Sollo et al. 2008, Sirianni et al. 2008).  Crosstalk between these 
two receptors can be important for cellular function.  Whereas G1 and PPT (GPR30 and 
ERα agonists, respectively) initiate estrogenic effects, ICI 182780 blocks the effects of 
estrogen because of inhibition of the ERα component of signaling (Sirianni et al. 2008).  
As such, estradiol has the potential to initiate several different cellular responses, some of 
which could be contradictory, depending on the type of receptor to which it binds. 
 
1.9  Summary 
Male/female differences in innate immune responses to bacterial infectio  are 
evident in human patients and rodent models of disease.  Females are less susceptible to 
the development of bacterial infections and subsequent bacteremia and sepsis, wherea 
males exhibit a greater incidence of such infections and are more likely to devel p fatal 
sequelae.  Females are protected from septic shock in two ways: 1) by producing lower 
levels of the proinflammatory cytokines responsible for the lethal nature of septic hock; 
2) by elevating the production of anti-inflammatory molecules.  Although evidence is 
accumulating that sex differences exist at the level of expression of PRRs for bacterial 
motifs and downstream signaling pathways, the mechanism of action is controversial as 
cells from males express higher levels of TLR4 and its co-receptors, whereas LPS-
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induced signaling pathways in female cells are more efficient at recognizing bacterial 
pathogens than are male cells. 
The observed differences in susceptibility to bacteria and endotoxin between the 
sexes may be caused by the actions of sex steroids.  Both age and reproductive status 
significantly influence the severity of bacterial infections and the incidence of sepsis.  
Testosterone also increases susceptibility to infection in rodent models, whereas estrogen 
generally reduces susceptibility.  Androgens, however, limit the production of key 
inflammatory mediators by immune cells following bacterial endotoxin exposure.  
Conversely, the role played by estrogens is debated, with evidence for both enhancement 
and suppression of immune responses.  A possible mechanism for the effects of sex 
hormones on immune responses to bacterial pathogens may be that testosterone and 
estrogen exert direct effects on the expression of PRRs, including TLR4 and its co-
receptors, and can modulate the signal transduction pathways employed by these 
receptors to initiate cytokine expression.  Consequently, sex hormones affect 
proinflammatory cytokine expression.  As such, it is the goal of this dissertation to 
elucidate some of the controversy surrounding the roles of reproductive hormones in 








FIGURE 1:  Physiological changes associated with sepsis.  Immune sentinel cells 
responding to LPS release inflammatory mediators (panel A) that in turn act on trget 
tissues to cause vasodilation, decreased perfusion, inflammation, and tissue damage 







FIGURE 2:  Mechanisms underlying LPS-induced inflammatory cytokine production by 
host sentinel cells and possible points of regulation by reproductive hormones.  LBP: 
lipopolysaccharide binding protein, LPS: lipopolysaccharide, TLR4: Toll-like recptor 4,  
p38 MAPK: mitogen-activated protein kinase p38, NF-κB: nuclear factor kappa B, E2: 
estrogens (and pink arrow), T: testosterone (and blue arrow).  Plus sign indicates a 
stimulatory effect while negative sign indicates an inhibitory effect, and question mark 









CHAPTER TWO: MATERIALS AND METHODS 
 
 
2.1  Macrophage-like cell line culture 
RAW 264.7 macrophage-like cells originally derived from male cells (CRL-2278; 
ATCC, Manassas, VA, USA) were grown on Cellstar culture plates (Greiner Bio-one, 
Monroe, NC) in RPMI 1640 (Cellgro, Washington, DC) containing 2% NuSerum (BD, 
Franklin Lakes, NJ) to minimize exposure to reproductive hormones.  According to the 
determinations of NuSerum reproductive hormone content provided by the manufacturer, 
cells cultured under these conditions are exposed to less than 2.6 X 10-10M testosterone, 
less than 2.5 X 10-10M 17β-estradiol, and less than 3.1 x 10-10M progesterone.  Some 
cells were co-cultured with varying doses of estradiol (Sigma Aldrich Co., St. Louis, 
MO), testosterone (Sigma Aldrich Co., St. Louis, MO), ICI 182780 (Tocris Bioscience, 
Ellisville, MO), or G1 (Cayman Chemical, Ann Arbor, MI). 
 
2.2  Surgical orchidectomy and ovariectomy, and hormone replacement 
Male and female C57BL/6 mice (Jackson Laboratory, Bar Harbor, ME, USA), 8 
weeks of age, underwent bilateral gonadectomy under inhalant isoflurane anesthesia.  
Male mice underwent orchidectomy via scrotal incision to remove the main endogenous 
source of testosterone.  Female mice underwent bilateral ovariectomy under inhalant 
isoflurane anesthesia to remove the main endogenous source of estrogens.  Groups of 
adult mice were bilaterally gonadectomized or sham gonadectomized and allowed to 
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recover for five weeks.  This time period not only ensures that androgens produced by th  
testis and estrogens produced by the ovary have been metabolized and are no longer 
present in the blood (Merkel et al. 2001), it is also sufficient to allow the turnover of 
immune cells generated under the influence of these reproductive hormones.  Mic  in the 
sham-operated group underwent the same anesthesia and incision procedure but the 
gonads were not excised.   
Hormone replacement was achieved as follows.  Male orchidectomized mice 
received subcutaneous injections of testosterone proprionate in corn oil (5 mg/kg)every 
three days for five weeks.  Female hormone replacement was achieved essentially as 
described previously by Cohen and collegues (1993).  Immediately following 
ovariectomy, silastic tubing (Dow Corning; Midland MI) containing 17β-estradiol (3.97 
+/- 0.18 mg/implant) and/or progesterone (4.74 +/- 0.18 mg/implant) (Sigma Aldrich Co., 
St. Louis, MO) was implanted subcutaneously to deliver exogenous hormone throughout 
the five week experimental period.  Hormone packed in silastic tubing implants have 
previously been shown to provide elevated levels of hormone for this time period (Cohen 
et al. 1993).  This resulted in five in vivo groups: intact sham operated animals (SHAM), 
ovariectomized animals (OVX), ovariectomized animals receiving progesterone implants 
(OVX+P4), ovariectomized animals receiving estradiol implants (OVX+E2), and 
ovariectomized animals receiving both progesterone and estradiol implants 
(OVX+E2+P4).  All procedures were approved by the Institutional Animal Care and Use 
Committee of The University of North Carolina at Charlotte. 
 
2.3  In vivo endotoxin treatment 
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 Gonadectomized, sham operated, and gonadectomized animals receiving hormone 
replacement were given intraperitoneal (i.p.) injections of lipopolysaccharide (LPS) (5 
mg/kg) isolated from E. coli (> 500,000 EU/mg; Sigma Chemical Co., St. Louis, MO).  
At varying time points post-treatment, animals were studied for behavior and appearance 
prior to euthanasia and analysis of sera content.  The severity of endotoxic shock was 
scored according to a system modified from that previously employed by Liu et al. 
(2005), in which a score of 1 was given to mice with ruffled fur but no detectable 
behavioral differences compared to untreated mice, a score of 2 was given to mice with 
percolated fur and a huddle reflex but that were still active, a score of 3 was given to 
mice that were less active and were relatively passive when handled, a score of 4 was 
assigned to inactive mice that exhibited only limited response when handled, and a score 
of 5 was given to moribund mice. 
 
2.4  Isolation of murine peritoneal macrophages 
Elicited peritoneal macrophages were isolated as previously described by our 
laboratory (Marriott et al. 1998, Marriott et al. 2000, Marriott et al. 2006).  Briefly, mice 
from each treatment group received intraperitoneal injections of 200 µl incomplete 
Freunds adjuvant (Sigma-Aldrich, St. Louis, MO).  Three days later, the peritoneal 
cavities were lavaged with RPMI 1640 (7 x 1.5 ml per animal) containing 10% FBS 
(Atlanta Biologics, Norcross, GA) to remove the peritoneal macrophages.  After washing 
twice in RPMI 1640, adherent macrophages were cultured in RPMI 1640 containing 2% 





2.5  Isolation and cell culture of bone marrow-derived macrophages 
Mice were euthanized and marrow was flushed from isolated femurs with RPMI 
1640 (Cellgro, Washington, DC) containing 10% FBS (Atlanta Biologics, Norcross, GA) 
to isolate bone marrow cells.  After washing twice in RPMI 1640, adherent cells were 
cultured in RPMI 1640 containing gentomycin, 2% NuSerum (BD, Franklin Lakes, NJ, 
USA) to minimize exposure to reproductive hormones, and 25% LADMAC media as a 
source of macrophage colony stimulating factor (M-CSF) to elicit macrophage 
development.  Cells were cultured for up to two weeks, and some groups were co-
cultured with varying doses of estradiol (Sigma Aldrich Co., St. Louis, MO). 
 
2.6  Assessment of TLR4/MD-2, CD14, and LPS binding by flow cytometry 
Immunofluorescence analysis (FACSCalibur, Becton Dickinson, San Jose, CA) 
was performed to determine the presence of CD14 or TLR4 associated with the 
permissive molecule MD-2 on the surface of macrophages as previously described by our 
laboratory (Marriott et al. 2006).  Cells were isolated and a phycoerythrin-conjugated 
antibody directed against TLR4/MD-2 (Clone MTS510, eBioscience) or a FITC-
conjugated antibody directed against CD14 (Clone rmC5-3) was added for 45 min at 4ºC.  
Cells were then washed and assayed by FACS analysis for the proportion of CD14 or 
TLR4/MD-2 positive cells relative to fluorescence obtained in cells stained with an 
FITC- or PE-conjugated antibody directed against an irrelevant peptide as appropriate.  In 
some experiments, cells were permeabilized during immunofluorescent staining to assess 
total cellular TLR4 content using a CytoFix/CytoPerm kit according to directions 
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provided by the manufacturer (BD PharMingen, San Diego, CA).  In some experiments, 
Alexa Fluor 488 labeled LPS (E. coli serotype 055:B5; Invitrogen, Eugene, OR) was used 
to measure binding of endotoxin to isolated macrophages.  Macrophages were co-
cultured with 400 ng/ml labeled LPS for 45 minutes prior to washing and assessment of 
the proportion of positive cells.  In all cytometric analyses, a minimum of 50,000 cells 
were analyzed from at least three separate cell isolation procedures and results are 
presented as the geometric means of the fluorescence intensity. 
 
2.7  Quantification of TNF-α, IL-6, IL-10, LBP, and PGE2 production 
Capture ELISAs were performed to quantify interleukin 6 (IL-6) levels using a 
commercially available capture antibody against IL-6 (clones MP5-20F3; BD 
PharMingen), a biotinylated anti-mouse IL-6 antibody (clones MP5-32C11; BD 
PharMingen), and streptavidin-horseradish peroxidase (BD Pharmingen).  A standard 
curve was constructed using varying dilutions of mouse recombinant IL-6 (BD 
PharMingen).  Tumor necrosis factor alpha (TNF-α), interleukin 10 (IL-10), and LBP 
levels were quantified using commercially available ELISA kits according to the 
directions provided by the manufacturers (TNF-α and IL-10; R&D System, Minneapolis, 
MN. LBP; HyCult Biotechnology, Canton, MA).  The minimum detectable levels in 
these assays were 4 pg/ml for IL-6, 16 pg/ml for TNF-α, 8 pg/ml for IL-10, and 3 ng/ml 
for LBP.  Prostaglandin E2 (PGE2) levels were quantified using a commercially available 
EIA kit according to the directions provided by the manufacturer (Assay Designs, Ann 
Arbor, MI), and the minimum detectable level in this assay was 39.1 pg/ml for PGE2.  All 




2.8  Quantification of sera hormone levels 
 Sera estradiol and progesterone levels were quantified at the time of sacrifice 
using commercially available EIA assays according to the directions provided by the 
manufacturer (Oxford Biomedical Research, Oxford, MI). 
 
2.9  Isolation of RNA and semi-quantitative reverse transcribed PCR 
Total RNA was isolated from macrophages using TRIzol reagent (Invitrogen, 
Carlsbad, CA) and was reverse transcribed in the presence of random hexomers using 
200 U RNase H-, Moloney leukemia virus reverse transcriptase (RT) (Promega, Madison, 
WI) in the buffer supplied by the manufacturer.  Polymerase chain reactions (PCR) were 
performed to determine the expression of mRNA encoding GPR30.  Positive and 
negative strand PCR primers used, respectively, were 5’-
AAGCCATGGATGCGACTACT-3’ and 5’-CGCCAGGTTGATGAACA-3’ to amplify 
mRNA encoding murine GPR30 (311 bp fragment).  Primers were designed by using 
Oligo 4.0 primer analysis software (National Biosciences Inc., Plymouth, MA) based on 
their location in different exons of the genomic sequences for GPR30 in addition to their 
lack of significant homology to sequences present in GenBank (MacVector Sequenc 
analysis software, IBI, New Haven CT).  The identity of the PCR amplified fragments 
was verified by size comparison with DNA standards (Promega).  The input RNA was 





2.10  Western blot analysis for GPR30 
 Protein samples were collected from macrophages using a SDS protein buffer 
containing 125 mm Tris Base, 20% glycerol, 2% lauryl sulfate, 0.01% BPB, and 2% 2-
mercaptoethanol.  Protein samples were electrophoresed on SDS-polyacrylamide gels and 
transferred to Immobilon-P Transfer Membranes (Milipore, Bedford, MA).  A rabbit anti-
human polyclonal primary antibody (which cross reacts with mouse) as used to detec  
GPR30 (MBL International, Woburn, MA) at a 1:500 dilution.  After reacting with the 
primary antibody, blots were washed and incubated in the presence of an anti-rabbit IgG 
antibody conjugated to horseradish peroxidase (Cell Signaling Technology, Beverly, 
MA).  Bound enzyme was detected with the enhanced chemiluminescent (ECL) system
(Amersham Pharmacia Biotech, Arlington Heights, IL).  Blots were exposed t  Pierce 
CL-X Posure Film (Pierce, Rockford, IL) for one hour and developed. 
 
2.11  Silencing RNA-mediated GPR30 knockdown 
        Three validated Stealth RNAi™ siRNA duplexes targeting murine GPR30, as well 
as universal negative control siRNA not homologous to anything in the vertebrate 
transcriptome, were purchased from Invitrogen (Carlsbad, CA).  RAW 264.7 cells were 
transfected with siRNAs using Tfx-20 transfection reagent (Promega, Madison, WI) 
according to the directions provided by the manufacturer.  GPR30 siRNA duplex Oligo 
ID: MSS233774 was chosen based on optimization experiments using RAW 264.7 cells 
and the Tfx-20 transfection reagent.  Serum-free media was replaced with complete 
media following one hour transfection.  At 48 hours after transfection, cells were assayed 
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for efficiency of knockdown, as assessed by PCR, and TLR4 levels, as assessed by flow 
cytometry. 
 
2.12  Statistical analyses 
Geometric means of immunofluorescence histogram plots were obtained using 
commercially available software (CellQuest, Becton Dickinson).  Geometric means of 
immunofluorescence histograms or mean cytokine levels were tested statistically against 
values for these parameters obtained from untreated cells or cells derived from sham 
operated animals using a Student's t test, a paired Student’s t test, or a one way ANOVA 
as appropriate using commercially available software (SAS v9.1.3, SAS Institute Inc., 
Cary, NC).  In all experiments, results were considered statistically significant when a P-
value of less than 0.05 was obtained.  Results are presented as the mean or the geometric








CHAPTER THREE: TESTOSTERONE REDUCES MURINE MACROPHAGE 




Sex differences have long been known to be a contributory factor in the incidence 
and progression of disorders associated with immune system dysregulation (as reviewed 
in Beery et al. 2003).  More recently, evidence has accumulated that sex may also play an 
important role in infectious disease susceptibility (as reviewed in Marriott and Huet-
Hudson 2006).  In general, females generate more robust and potentially protective 
humoral and cell-mediated immune responses following antigenic challenge than their 
male counterparts.  For example, influenza infection elicits greater sev ity and 
hospitalization in male patients (Quach et al. 2003), and females generate gr ater humoral 
and cell mediated responses to herpes simplex viruses (Knoblich et al. 1983) and 
cytomegalovirus (Villacres et al. 2004).  Women have been found to have higher 
circulating levels of IgM than men (Butterworth et al. 1967) and this difference is most 
apparent at puberty (Lichtman et al. 1967, Grundbacher 1972) suggesting a role for 
reproductive hormones in the development of this gender bias.  Furthermore, cell-
mediated host responses have also been suggested to exhibit sexual dimorphism and 
female mice have been shown to mount more vigorous T-cell responses to exogenous and 
allogeneic antigens than males (Weinstein et al. 1984).  This notion is further supported 
by the observation that early cell-mediated immune responses to thermal injury are more 
robust in females than their male counterparts (Gregory et al. 2000b).   
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Differences in immune responses between males and females have generally be n 
assumed to be a consequence of the actions of reproductive hormones. Androgens have 
been shown to have suppressive effects on immune functions following trauma or 
trauma-hemorrhage and subsequent sepsis (Wichmann et al. 1996, Angele et al. 1999, 
Angele et al. 2000).  Furthermore, testosterone and other androgens such as 
dihydrotestosterone, have been shown to decrease immunoglobulin and cytokine 
production, and to limit lymphocyte proliferation (as reviewed in Angele et al. 2000 and 
Olsen and Kovacs 1996).  These observations are consistent with the demonstration that 
exogenous testosterone administration increases female susceptibility to M. marinum 
infection, and castration attenuates such infections in male mice (Yamamoto et al. 1991).  
While classical androgen receptors do not appear to be expressed by macrophages, recent 
studies suggest that these important sentinel cells possess non-classical cell surface 
receptors for male sex hormones (Liu et al. 2005).  The presence of such receptors could 
explain the documented ability of testosterone to down-regulate LPS-induced activation 
of the pro-inflammatory transcriptional regulators and immune responses in isolated 
macrophages (Benten et al 2004).  To date, it is unclear how testosterone alters the 
immune responsiveness of macrophages.   
In the present study we demonstrate that testosterone reduces expression of TLR4
on a macrophage cell-line and cultured primary macrophages.  Furthermore, we have 
extended these in vitro findings to an in vivo analysis of TLR4 expression on 
monocytes/macrophages and report an increase in TLR4 levels on these cells in th  
absence of endogenous testosterone.  Taken together, these data are in agreement with th  
recent observation that TLR4 expression is increased in the prostate following castration 
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(Quintar et al. 2006) and provides a potential mechanism underlying the 
immunosuppressive effects of testosterone. 
 
3.2 Results 
To begin to determine the in vitro effects of testosterone on cell surface TLR4 
expression we have utilized a murine macrophage-like cell line, RAW 264.7.  This cell 
line was cultured in media containing 2% NuSerum, conditions designed to minimize 
exposure to reproductive hormones.  These cells were exposed to varying concentrations 
of testosterone propionate (1-1000 nM) for various time periods prior to analysis of cell 
surface TLR4 by flow cytometry.  As shown in Figure 3A and 3B, testosterone elicit d 
an approximately 10% reduction in fluorescence attributable to cell surface TLR4 at 
doses as low as 100 nM (final ethanol concentration of 0.0002%) and this effect was 
significant (n = 16 per group, p < 0.05) at a dose of 1 µM (final ethanol concentration of 
0.002%).  This effect was most apparent at 24 hours following testosterone 
administration (Figure 3C). 
To determine whether the reduction in cell surface TLR4 expression was due to 
receptor internalization, we have assessed the effect of testosterone on relative TLR4 
protein content in permeabilized cells by flow cytometry.   In these studies, 24 hour 
treatment of RAW 264.7 cells with 1 µM testosterone elicited a statistically significant 
7.3% decrease in cellular TLR4-asssociated fluorescence (fluorescence geom tric means 
of 7.37 +/- 0.14 versus 6.83 +/- 0.13 in untreated and testosterone treated cells, 
respectively; n = 12 per group, p < 0.05) indicating that receptor internalization does not 
account for the apparent decrease in cell surface TLR4 expression in this cell line. 
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To begin to assess the functional significance of testosterone-mediated decrases 
in TLR4 expression in this macrophage-like cell line, we have determined whether 
testosterone alters the sensitivity of these cells to the TLR4 ligand, LPS.  RAW 264.7 
cells were exposed to testosterone (1 µM) for 24 hours prior to challenge with LPS (250 
ng/ml) and the production of the inflammatory cytokine, TNF-α, was assessed after 12 
hours by specific capture ELISA.  We report that testosterone significantly decreased 
LPS-induced TNF-α production from 703 +/- 15 pg/ml to 620 +/- 20 pg/ml (n = 12 per 
group, p < 0.05) consistent with a decreased functional responsiveness of these cells to 
this TLR4 ligand. 
 Having determined optimal doses and kinetics using a cell line, we have 
confirmed the effect of testosterone on TLR4 expression in primary murine peritoneal 
macrophages.  Macrophages were elicited from orchidectomized animals that are largely 
devoid of endogenous androgens, sham orchidectomized mice, and orchidectomized mice 
with testosterone replacement.  Cells were cultured either in the presence or absence of 1 
µM testosterone and TLR4 cell surface expression was assessed at 24 hours post 
testosterone treatment by flow cytometry.  As shown in Figure 4, testosterone treatment 
again elicited a modest but significant decrease in cell surface expression of TLR4 on 
macrophages derived from orchidectomized mice (n = 16 per group, p < 0.05, paired 
Student's t test).  In contrast, cells derived from orchidectomized mice that rceived in 
vivo testosterone replacement or sham orchidectomized mice failed to show sensitivity to 
in vitro testosterone addition, suggesting that the effects of this hormone are long lasti  
and maximal at even endogenous levels. 
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To determine whether the reduction in cell surface TLR4 expression was due to 
receptor internalization or decreased TLR4 protein levels, we have assessed the effect of 
testosterone on relative TLR4 protein content in permeabilized cells by flow cyt metry.   
In these studies, 24 hour treatment of primary macrophages with 1 µM testosterone 
decreased TLR4-associated fluorescence in cells from 5 of 7 orchidectomized animals 
with an average decrease of 13.8% (fluorescence geometric means of 7.60 +/- 0.62 versus 
6.55 +/- 0.58 in untreated and testosterone treated cells, respectively; n = 5, p < 0.05) 
indicating that testosterone induced decreases in cell surface TLR4 expression cannot be 
explained on the basis of receptor internalization. 
To begin to assess the functional significance of testosterone-mediated decrases 
in TLR4 expression in primary macrophages, we have determined whether testosterone 
alters the sensitivity of these cells to LPS.  Peritoneal macrophages wer  again isolated 
from orchidectomized and sham orchidectomized animals, and orchidectomized mice 
with testosterone replacement, and cells were cultured either in the presence or absence 
of 1 µM testosterone.  At 24 hours post testosterone treatment, cells were challenged with 
LPS (250 ng/ml) and the production of the inflammatory cytokine, TNF-α, was assessed 
by specific capture ELISA.  As shown in Figure 5, testosterone significantly decreased 
LPS-induced TNF-α production by cells derived from orchidectomized mice (n = 16 per 
group, p < 0.05, paired Student's t test) consistent with a decreased functional 
responsiveness of these cells to this TLR4 ligand.  In agreement with the inability of 
testosterone to reduce TLR4 expression on cells derived from sham orchidectomized 
mice or orchidectomized mice that received testosterone replacement (Figure 4), 
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testosterone failed to elicit significant decreases in LPS sensitivity in these cells (Figure 
5). 
 To confirm that testosterone suppresses cell surface TLR4 expression on these 
immune cells in vivo, we have examined TLR4 expression on monocytes/macrophages 
acutely isolated from orchidectomized, sham orchidectomized, and orchidectomized mice 
that received testosterone replacement.  As shown in Figure 6A, orchidectomy elicits a 
significant decrease (n = 16 animals per group, p < 0.05) in animal body weight that is 
prevented by exogenous testosterone replacement as previously reported (Hooper et al. 
1986).  Peritoneal monocytes/macrophages from sham orchidectomized animals express 
very low levels of cell surface TLR4 (Figures 6B and C).  Importantly, cels from 
orchidectomized mice express approximately 25% greater TLR4 expression (n = 16 
animals per group, p < 0.05) than sham operated animals.  This effect was largely 
abolished in cells derived from animals that received exogenous testosterone replac ment 
(Figures 6B and C).  These data indicate removal of endogenous testosterone, and hence 
elimination of its suppressive effects, elevates in vivo TLR4 expression on this key 
sentinel immune cell type. 
 To begin to test the physiological relevance of these changes in TLR4 expression, 
we have investigated the susceptibility of male mice to endotoxic shock following 
removal of endogenous testosterone.   Orchidectomized, sham orchidectomized, and 
orchidectomized mice that received testosterone replacement, were challenged with a 
sub-lethal dose of LPS (5 mg/kg, i.p.).  At 24 hours post-treatment the severity of 
endotoxic shock was assessed according to appearance and behavior using a scoring 
system modified from that employed by Liu and colleagues (2006).  Animals were then 
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euthanized and sera isolated for inflammatory cytokine content.   As shown in Figure 7, 
orchidectomized  mice exhibited a markedly elevated susceptibility to endotoxin to that 
seen in sham treated animals with a close correlation between severity scores and sera 
levels of the inflammatory cytokine, IL-6 (n = 6-7 animals per group, p < 0.05).  
Importantly, this effect was abolished in animals that received exogenous testosterone 
replacement (Figures 7A and 7B).  These data indicate removal of endogenous 
testosterone elevates susceptibility to endotoxic shock and is consistent with the observed 
in vivo increase in TLR4 expression on immune cells. 
 
3.3 Conclusions 
It has recently been recognized that sex based differences may influence host 
responses to infectious organisms.  Examples include the observation that female deer 
have lower parasite loads than males and the finding that helminth infections are 
generally more severe in males than females (Zuk and McKean 1996, Poulin 1996).  
These phenomena appear to correlate with clinical and laboratory studies demonstrating 
that females generally exhibit greater adaptive immune responses following antigenic 
challenge than males (as reviewed in Marriott and Huet-Hudson 2006).  Importantly, 
many of these differences become apparent at puberty (Lichtman et al. 1967, 
Grundbacher 1972) suggesting a role for reproductive hormones in their development and 
this hypothesis has been supported by the finding that receptors for reproductive 
hormones have been found in a variety of immune cells types (as reviewed in Angele et 
al. 2000).  Androgens have been shown to have suppressive effects on immune functions 
following trauma or trauma-hemorrhage and subsequent sepsis (Wichmann et al. 1996, 
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Angele et al. 1999, Angele et al 2000).  Furthermore, male reproductive hormones have 
been shown to decrease immunoglobulin and cytokine production, and to limit 
lymphocyte proliferation (as reviewed in Angele et al. 2000 and Olsen and Kovacs 1996).  
These observations are consistent with the demonstration that exogenous testosterone 
administration increases female susceptibility to M. marinum infection, and castration 
attenuates such infections in male mice (Yamamoto et al. 1991).  Recent studies suggest 
that macrophages, a key sentinel immune cell type, possess non-classical cell surface 
receptors for androgens (Liu et al. 1005) and that testosterone can decrease LPS-induced 
activation of transcription factors that regulate inflammatory responses (Benten et al. 
2004).  However, it is currently unclear how testosterone alters the immune 
responsiveness of macrophages. 
In the present study we demonstrate that in vitro exposure to testosterone elicits 
significant decreases in the expression of cell surface TLR4 in a macrophage-like cell 
line and we have confirmed this effect in primary murine macrophages.  Interestingly, we 
show that the ability of testosterone to decrease TLR4 expression on primary 
macrophages is only apparent on cells derived in the absence of endogenous gonadal 
androgens as cells isolated from sham orchidectomized animals or orchidectomz d 
animals that receive testosterone replacement fail to demonstrate such sensitivity.  This 
finding suggests that endogenous testosterone exerts sustained effects on cell urfa  
TLR4 molecule expression and is characteristic of the long lasting actions of reproductive 
steroid hormones on cellular machinery.  The testosterone-mediated decrease in cll 
surface TLR4 expression does not appear to be due to receptor internalization as 
significant decreases in TLR4 expression were also observed in permeabilized ce ls. 
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Furthermore, we have demonstrated the ability of endogenous testosterone to 
decrease TLR4 expression on immune cells in vivo by showing that levels of this 
microbial pattern recognition receptor on acutely isolated peritoneal 
monocytes/macrophages derived from orchidectomized mice are significantly higher than 
those seen on cells obtained from sham orchidectomized animals or orchidectomized 
animals that received testosterone replacement.   Importantly, this elevation in TLR4 
expression in vivo correlates with a dramatic increase in endotoxin susceptibility in 
orchidectomized animals.  Taken together, the present findings demonstrate that the 
presence of testosterone in vitro or in vivo significantly decreases the cell surface 
expression of a critical receptor for microbial components and inflammatory signal  
liberated from injured tissues on an important sentinel immune cell type. 
In our in vitro studies, acute administration of exogenous testosterone evoked 
maximal reductions of 7-10% in TLR4 expression on macrophages and one might be 
tempted to question the functional significance of such an effect.  However, it is 
important to note that the number of these receptor molecules on the surface of immune 
cells is relatively low and so even modest changes in the level of expression may have 
marked effects on cellular responsiveness.  In this study, we have begun to assess the 
functional relevancy of testosterone-mediated reductions in TLR4 expression by 
measuring inflammatory cytokine production elicited by a TLR4-specific ligand.  We 
show that testosterone significantly decreases LPS-induced TNF-α production by 
primary macrophages generated in the absence of endogenous androgens and a 
macrophage-like cell line and, while we cannot rule out possible effects of testosterone 
on the signal transduction pathway, its effects on inflammatory cytokine production 
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correlate well with the observed changes in TLR4 expression.  If these in vitro findings 
were reproduced in vivo, then a 10% difference in inflammatory mediator production 
would be anticipated to have profound effects on disease outcome.  However, it is quite 
possible that our in vitro studies underestimate the chronic influence of testosterone on 
immune cell function.  This notion is supported by our in vivo studies showing that the 
removal of endogenous testosterone elicits a more marked effect on TLR4 expression on 
in situ monocytes/macrophages that that seen in vitro.  Importantly, this effect correlates 
with a profound increase in susceptibility to in vivo endotoxin challenge. 
Our results are in agreement with a recent study demonstrating that the androgen, 
dihydrotestosterone can inhibit the expression of mRNA encoding TLR4 in human 
endothelial cells derived from neonatal tissue and can reduce LPS-mediated 
inflammatory mediator production by this cell type (Norata et al. 2006).  In addition, the 
present in vivo studies also support the findings of Quintar and colleagues (2006) 
showing that prostate TLR4 protein expression is elevated in castrated rats.  Furthermore, 
the present study could provide a mechanism underlying the ability of testosterone o 
down-regulate LPS-induced activation of the pro-inflammatory transcriptional regulator, 
p38 MAP kinase, and reduce nitric oxide production in macrophage-like cell lines 
(Benten et al. 2004).  However, it is important to note that the cellular effects of 
reproductive hormones are complex and so ascribing specific roles to each hormone is 
fraught with peril.  For example, while a number of studies indicate that testosterone 
alters inflammatory cytokine release by macrophages following bacteri l endotoxin 
exposure (Angele et al. 1998a and 1998b), others have provided contrary evidence and 
this has led to the suggestion that male reproductive hormones only exert such effects in 
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immunocompromised hosts (Angele et al. 1999).  As such, while it is apparent that the 
precise role of testosterone in the regulation of immune function remains contentious, the 
present demonstration that testosterone can modulate the expression of a key receptor for 
"danger signals" in vitro and in immune competent animals may represent an important 








FIGURE 3:  Testosterone decreases cell surface TLR4 expression on a macrophage-like 
cell line in a dose and time dependant manner as determined by flow cytometry.  RAW 
264.7 cells were cultured in 2% NuSerum-containing media to minimize exposure to 
reproductive hormones and were untreated (0) or exposed to varying concentration of 
testosterone for indicated times and analyzed for cell surface TLR4 by flow cyt metry.   
Panel A is a representative experiment showing changes in TLR4 immunofluorescenc  
following 24 hr exposure to 1 µM testosterone.  Trace labeled Irrelevant indicates 
fluorescence obtained with a control antibody directed against an irrelevant antigen.  
Panel B shows the average immunofluorescence intensity (as geometric means) following 
exposure to increasing doses of testosterone (1-1000 nM).  N = 10 per group, asterisk
indicates significant difference from untreated cells.  Panel C shows average 
immunofluorescence intensity (as geometric means) following exposed to testosterone (1 









FIGURE 4:  Testosterone decreases cell surface TLR4 expression on cultured primary 
macrophages derived from animals largely devoid of endogenous androgens.  
Macrophages were isolated from orchidectomized (Orch) or sham orchidectomized 
(Sham Orch) mice or animals that were orchidectomized and received s.c. injections of 
testosterone (Orch + T).  Cells were untreated or exposed to testosterone (1 µM) for 24 
hrs and analyzed for cell surface TLR4 by flow cytometry.  Panel A is a representative 
experiment showing changes in TLR4 immunofluorescence on macrophages from an 
orchidectomized mouse following exposure to 1 µM testosterone.  Trace labeled 
Irrelevant indicates fluorescence obtained with a control antibody directed against an 
irrelevant antigen.  Panel B shows average TLR4 immunofluorescence intensities (as 
geometric means) following exposure to testosterone (T).  N = 16 animals per group, 
asterisk indicates significant difference from untreated cells as determined by paired 







FIGURE 5:  Testosterone decreases TLR4-mediated inflammatory cytokine production 
by cultured primary macrophages derived from animals largely devoid of endogenous 
androgens.  Macrophages were isolated from orchidectomized (Orch) or sham 
orchidectomized (Sham Orch) mice or animals that were orchidectomized and received 
s.c. injections of testosterone (Orch + T).  Cells were untreated (0) or exposed to 
testosterone (T; 1 µM) for 24 hrs.  These cells were then challenged with LPS (250 
ng/ml) for 12 hrs and culture supernatants were assayed for the presence of TNF-α by 
specific capture ELISA.  N = 16 animals per group, asterisk indicates statistically 
significant difference from cells that were not exposed to testosterone in vitro as 







FIGURE 6:  Endogenous testosterone decreases cell surface TLR4 expression on 
monocytes/macrophages in vivo.  Elicited peritoneal monocytes/macrophages were 
acutely isolated from orchidectomized (Orch) or sham orchidectomized (Sham Orch) 
mice or animals that were orchidectomized and received s.c. injections of testosterone 
(Orch + Testosterone) and analyzed for cell surface TLR4 expression by flow cytometry.  
Panel A shows changes in body weight with each treatment regimen and indicates that 
testosterone replacement reverses the weight loss observed following orchidectomy.  
Panel B is a representative experiment showing changes in TLR4 immunofluorescence 
on monocytes/macrophages derived from each treatment group.  Trace labeled Irrelevant 
indicates fluorescence obtained with a control antibody directed against an irrelevant 
antigen.  Panel C shows the average immunofluorescence intensities (as geometric 
means) of TLR4 expression on cells from each treatment group.  N = 16 animals per 








FIGURE 7:  Removal of endogenous testosterone elevates susceptibility to endotoxic 
shock in vivo.   Orchidectomized (Orch), sham orchidectomized (Sham), and 
orchidectomized mice that received testosterone replacement (Orch+T), were challenged 
with a sub-lethal dose of LPS (5 mg/kg, i.p.) for 24 hours.  Panel A: severity of endotoxic 
shock assessed according to appearance and behavior and reported as a severity score for 
each animal in the three treatment groups.  Severity was scored from 1 (no detectabl  
behavioral differences) to 5 (moribund).  Panel B: sera IL-6 content for each animalin 
the three treatment groups.  Bars indicate group averages and asterisks indicate 








CHAPTER FOUR:  ESTROGEN AUGMENTS CELL SURFACE TLR4 EXPRESSION 





It has become increasingly apparent that sexual dimorphism exists in infectious 
disease susceptibility (as reviewed in Marriott and Huet-Hudson 2006).  In general, 
females generate more robust and potentially protective humoral and cell-mediated 
immune responses following antigenic challenge than their male counterparts.  For 
example, it has been found that female deer have lower parasite loads than males, and 
helminth infections are generally more severe in males than females (Zuk and McKean 
1996, Poulin 1996).  In addition, influenza infection elicits greater severity and 
hospitalization in male patients (Quach et al. 2003).  Furthermore, this sexual 
dimorphism in susceptibility to infectious disease extends to cases of sepsis, where male 
patients exhibit a 70% mortality associated with sepsis, but females only show 26% 
associated mortality (Schroder et al. 1998).  Interestingly, women have been found to 
have higher circulating levels of IgM than men (Butterworth et al. 1967) and this 
difference is most apparent at puberty (Lichtman et al. 1967, Grundbacher 1972) 
suggesting a role for reproductive hormones in the development of this male/female bias.  
Estrogens have been found to promote increased resistance to streptococcal 
infections (Nicol et al. 1964) while androgens have been shown to suppress host immune 
responses (as reviewed in Angele et al. 2000 and Olsen and Kovacs 1996).  Indeed, high 
65 
 
levels of estrogens can elevate immune responses to a point at which they are detrimental 
to the host.  For example, estradiol or estriol treated rodents exhibit greater mor ality 
following gonococcal infection (Kita et al. 1985) or endotoxin challenge (Ikejima et al. 
1998), respectively, than untreated animals.  Furthermore, it has been found that sera 
levels of estradiol are increased in human sepsis patients, and the highest incidence and 
severity of sepsis is associated with high circulating levels of estrogns regardless of sex 
(Schroder et al. 1998, Fourrier et al. 1994, Dossett et al. 2008, May et al. 2008). 
The mechanisms underlying innate immune responses to bacterial endotoxins are 
only now becoming apparent.  As such, it is feasible that reproductive hormone-based 
differences in the level of expression of molecules that perceive bacterial motifs could 
lead to significant differences in the magnitude of inflammatory host responses following 
endotoxin exposure.  In this study, we show that removal of endogenous estrogens 
decreases circulating levels of key inflammatory mediators following in vivo endotoxin 
challenge.  Furthermore, we demonstrate that these changes are associated with decreased 
circulating levels of LBP and diminished cell surface expression of TLR4 on 
macrophages.  In contrast to our findings with testosterone, we show that acute in vitro 
exposure to exogenous estradiol fails to elicit significant changes in pattern recognition 
receptor expression on a macrophage-like cell line or authentic primary macrophages.  
However, in vivo administration of supra-physiological levels of estradiol result in a 
marked increase in endotoxin susceptibility and this effect is associated with significant 
increases in LBP levels and cell surface TLR4 and CD14 expression on macrophages.  
Taken together, these data provide a potential mechanism underlying the immuno-





To begin to determine the in vivo effects of female reproductive hormones, 
ovariectomized animals that are largely devoid of endogenous estrogens and sham 
ovariectomized animals were challenged with a sub-lethal dose of LPS (5 mg/kg, i.p.).  
Sera levels of estradiol were decreased by 61.4% in ovariectomized animals.  At 20 hrs 
after treatment the severity of endotoxic shock was assessed according to appearance and 
behavior using a scoring system modified from that employed by Liu et al. (2005).  
Animals were then euthanized and sera isolated for cytokine content by specific capture 
ELISAs.  As shown in Figure 8, ovariectomized animals exhibited markedly lowerLPS-
induced sera levels of IL-6 (Figure 8A) and TNF-α (Figure 8B) than age matched intact 
females (n = 6-7 animals per group; P < 0.05).  It is important to note that we did not 
observe significant differences in endotoxic shock severity scores between thes  groups 
(Figure 8C).  However, this observation could be explained by our finding that sera lev ls 
of the anti-inflammatory cytokine, IL-10, were also significantly higher (P < 0.05) in 
sham ovariectomized animals than in gonadectomized mice (Figure 8D).  Together, thes  
data show that removal of endogenous estrogens results in reduced host cytokine 
responses to endotoxin challenge.   
Having established that removal of endogenous estrogens reduced in vivo 
cytokine responses to LPS, we next investigated the influence of these reproductive 
hormones on the expression of key molecules used in the perception of this microbial 
product.  We have determined the circulating levels of LBP in sera isolated from 
ovariectomized and sham gonadectomized animals.  As shown in Figure 9A, circulating 
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levels of LBP were significantly lower in female mice following the removal of 
endogenous estrogens (n = 8-12 animals; P < 0.05).  To further determine the 
mechanisms underlying the effects of estrogens on LPS sensitivity, we have investigated 
the expression of pattern recognition receptors on acutely isolated macrophages from 
intact and gonadectomized female animals.  As shown in Figure 9B, peritoneal 
macrophages isolated from ovariectomized mice demonstrated a reduced ability to nd 
fluorescently labeled LPS than their intact animal-derived counterparts (n = 7-8 animals, 
P < 0.05).  Importantly, the diminished capacity of macrophages to bind LPS was 
mirrored by a significant reduction (n = 8-12 animals, P < 0.05) in the cell surface 
expression of TLR4 as determined by flow cytometry (Figure 9C).  Interestingly, this 
effect appears to be limited to TLR4, as the LPS co-receptor CD14 failed to demonstrate 
detectable differences in expression in the absence or presence of endogenous estrogen 
(Figure 9D).  Together, these data suggest that endogenous levels of estrogens in intact 
females may augment innate immune responses by elevating LBP production and cell 
surface TLR4 expression on a critical sentinel immune cell type. 
To determine if acute treatment of macrophages with estradiol can similarly 
elevate TLR4 expression on macrophages, we investigated the effects of exogenous 
estradiol on the macrophage-like cell line, RAW 264.7, and cultured primary 
macrophages derived from ovariectomized and sham ovariectomized animals.  As shown 
in Figure 10A, 24 hr treatment with estradiol (1 X 10-8 M and 1 X 10-10 M) failed to elicit 
significant effects on cell surface TLR4 expression on RAW 264.7 cells cultured in 
media containing 2% NuSerum to minimize exposure to reproductive hormones.  
Similarly, TLR4 expression was not altered on primary macrophages derive from either 
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ovariectomized or sham ovariectomized animals (Figure 10B).  Consistent with the data 
presented in Figure 10C, unstimulated cells from ovariectomized animals expressed 
significantly less cell surface TLR4 than cells derived from sham operated animals (7.72 
+/- 0.47 arbitrary units of fluorescence intensity versus 9.06 +/- 0.17, respectively) (P < 
0.05).  Together, these data indicate that acute in vitro exposure to physiological levels of 
estradiol is not sufficient to alter cell surface TLR4 expression on macrophages. 
To test the hypothesis that female reproductive hormones elevate the expression 
of key microbial pattern recognition receptor expression on innate immune sentinel cells 
in vivo, we tested the susceptibility of gonadectomized female mice to endotoxin 
challenge following long term high level estradiol and/or progesterone replacement.  
Mice were ovariectomized or sham ovariectomized and a group of the gonadectomized 
animals received silastic implants containing either estradiol, progesterone, or one 
implant of each estradiol and progesterone.  Such implants have been previously been 
shown to continually release hormone for at least 35 days (Cohen and Milligan 1993).  In 
the present study, the implants were not depleted at 5 weeks following ovariectomy.  
After sacrifice, implants were removed and weighed, and the presence of hormone 
contents confirmed visually.  On average, estradiol implant content weight decreas d 
from 3.97 +/- 0.18 mg to 2.83 +/- 0.20 mg, and progesterone implant content weight 
decreased from 4.74 +/- 0.18 mg to 1.99 +/- 0.08 mg.  Sera levels of estradiol were 390 
+/- 42 pg/ml at the time of sacrifice in animals receiving estradiol implants, far in excess 
of the sera levels of estradiol in intact females (56 +/- 38 pg/ml).  At sacrifice, sera levels 
of progesterone were 7.31 +/- 1.32 ng/ml in animals with progesterone implants, 
significantly higher than progesterone levels in intact females (3.35 +/- 0.67 ng/ml).   
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Interestingly, mice with estradiol implants showed a significant increase in 
susceptibility to LPS challenge (5 mg/kg, i.p.) over that seen in either intact mice or 
ovariectomized animals that did not receive estradiol replacement.  As shown in Figure 
11A, ovariectomized animals receiving exogenous estradiol showed significantly higher 
inflammatory cytokine levels at 8 hrs following endotoxin challenge than untreated 
gonadectomized or intact animals (n = 15, P < 0.05), an effect that was not seen in 
ovariectomized animals receiving exogenous progesterone treatment.  Furthermo e, 
ovariectomized animals receiving both estradiol and progesterone showed similar
elevations in inflammatory cytokine levels (n = 7-15, P<0.05).  This difference in 
inflammatory cytokine expression was associated with a dramatic increase in endotoxin 
susceptibility as assessed by severity scoring with almost all animals in the estradiol 
treatment group, as well as animals receiving both estradiol and progestern , becoming 
moribund as rapidly as 8 hrs post-challenge (Figure 11B).  While there was a trend for 
increased sera levels of the anti-inflammatory cytokine IL-10 in animals receiving 
estradiol treatment, this difference was not statistically significant. 
Importantly, these differences cannot be attributed to treatment-induced changes 
in body weight.  Prior to surgery, there was no significant difference among groups (18.0 
+/-0.3, 18.2 +/- 0.3, 18.3 +/- 0.3, 18.3 +/- 0.2, 17.9 +/- 0.4 g in SHAM, OVX, OVX+P4, 
OVX+E2, OVX+E2+P4, respectively).  While ovariectomized animals weighed 
significantly more than sham ovariectomized animals (20.6 +/- 0.2 versus 22.1 +/- 0.3 g 
in SHAM and OVX, respectively, P < 0.05), there was no difference between 
ovariectomized groups, regardless of hormone treatment (22.5 +/- 0.4, 22.0 +/- 0.3, 22.3 
+/- 0.4 g, in OVX+P4, OVX+E2, and OVX+E2+P4, respectively).  It is interesting to note 
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that neither of the groups receiving exogenous estradiol demonstrated a decrease in body 
weight following long-term ovariectomy.  While this was somewhat unexpected, it is 
possible that this result may be due to the long-term administration of high doses of this 
hormone.  Indeed, others have reported that ovariectomy and long-term exposure to 
estrogens either do not alter body weight or elicit only transient changes (Bryson and 
Bischoff 1979, Game et al. 2008). 
To investigate the mechanisms underlying the increased susceptibility of mice 
receiving high levels of exogenous estradiol to endotoxin challenge, we have assessed the 
relative expression of critical innate immune receptors for LPS in these animals.  Mice 
were ovariectomized, sham ovariectomized, or ovariectomized and given silastic 
implants containing estradiol, progesterone, or both estradiol and progesterone prior to 
isolation of sera and peritoneal macrophages.  As shown in Figure 12A, circulating levels 
of LBP were significantly higher in gonadectomized mice receiving exo nous estradiol 
than those in mice that did not receive this hormone or intact females (n = 3-8 animals; P 
< 0.05: ANOVA with Tukey’s post-hoc analysis).  Furthermore, peritoneal macrophages 
isolated from ovariectomized mice receiving estradiol replacement demonstrated a 
significantly greater ability to bind fluorescently labeled LPS (n = 4-8 anim ls, P < 0.05: 
ANOVA with Tukey’s post-hoc analysis) than those derived from animals that did not 
receive implants (Figure 12B).  Importantly, the increased ability of macrophages to bind 
LPS was mirrored by significant increases in the cell surface expression of CD14 (Figure 
12C) and TLR4 (Figure 12D) as determined by flow cytometry (n = 4-12; P < 0.05: 
ANOVA with Tukey’s post-hoc analysis).  Interestingly, this difference was not due 
simply to increased total cellular TLR4 expression, as evidenced by the absence of su h
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effects in permeabilized cells (Figure 12E).  Rather, these differences wer  due to a 
reduction in the relative proportion of these receptors on the cell surface. 
An ability of exogenous estradiol to reverse, and indeed augment, the 
susceptibility of ovariectomized female mice to endotoxin challenge suggests that this 
hormone alone mediates gonadectomy-induced effects on LPS sensitivity.  However, 
these data do not preclude the involvement of other female reproductive hormones 
including progesterone.  To investigate the role of this hormone on LPS receptor 
expression on a critical sentinel immune cell type, we also examined the effects of 
progesterone replacement on ovariectomy-induced changes in macrophage pattern 
recognition receptor expression.  As shown in Figure 12, the presence of progesterone-
containing implants failed to augment sera levels of LBP (Figure 12A), levels of LPS 
binding to macrophages (Figure 12B), cell surface levels of CD14 on these cells (Figure 
12C), or either cell surface TLR4 expression or total TLR4 content in macrophages 
(Figures 12D and 12E, respectively).  Similarly, co-administration of progesterone with 
estradiol failed to significantly effect expression of most of these parameters compared to 
estradiol treatment alone (Figure 12). While co-administration of progesterone with 
estradiol did significantly increase LPS binding to acutely isolated macrophages (Figure 
12B), it is important to note that no significant changes in cellular CD14 or TLR4 
expression were observed and so the mechanisms underlying this effect are unclear. 
 
4.3 Conclusions 
It has recently been recognized that sex based differences may influence host 
responses to infectious organisms.  In general, females generate more robust and 
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potentially protective humoral and cell-mediated immune responses following antgenic 
challenge than their male counterparts (as reviewed in Marriott and Huet-Hudson 2006).  
Studies have found that females generate greater immune responses and exhibit less 
hospitalization associated with viral infections (Quach et al. 2003, Knoblich et al. 1983, 
Villacres et al. 2004).  Furthermore, males have been found to have more severe parasitic
infections than their female counterparts (Zuk and McKean 1996,  Poulin 1996).  
Importantly, many of these differences become apparent at puberty (Lichtman e  al. 1967, 
Grundbacher 1972) suggesting a role for reproductive hormones in their development and 
this hypothesis has been supported by the finding that receptors for reproductive 
hormones have been found in a variety of immune cells types (as reviewed in Angele et 
al. 2000).  Estrogens have been demonstrated to increase resistance to streptococcal 
infections (Nicol et al. 1964) while the removal of endogenous estrogens have been 
shown to markedly increase the severity of M. avium infections, an effect that can be 
reversed following estradiol replacement (Tsuyuguchi et al. 2001).  However, the role 
played by estrogens and other female reproductive hormones in susceptibility to acute 
infection and/or sepsis has not been defined. 
In the present study we demonstrate that removal of endogenous estrogen results 
in reduced production of cytokines following endotoxin challenge.  While circulating 
levels of the inflammatory cytokines, IL-6 and TNF-α, are decreased following estrogen 
removal, levels of the anti-inflammatory cytokine, IL-10, are also reduced.  This finding 
could account for an apparent lack of significant effects of ovariectomy on endotoxin 
susceptibility as assessed by severity scoring.  Indeed, it has been sugg sted that the 
immunosuppressive effects of IL-10 limit the lethal sequelae associated with excessive 
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pro-inflammatory cytokine production and protect against endotoxemia (Londono et al. 
2008, Emmanuilidis et al. 2001, van der Poll et al. 1995).  IL-10 deficient mice exhibit 
increased bacteriemia, increased inflammatory TNF-α secretion, and increased mortality 
associated with bacterial infection (Londono et al. 2008). 
Importantly, this decreased cytokine response to endotoxin administration 
following removal of estrogens occurs in association with a corresponding decrease in the 
cell surface expression of a key microbial pattern recognition receptor for LPS, TLR4, 
and diminished sera levels of the permissive protein LBP.  These findings are consistent 
with the recent observation that ovariectomy results in lower expression of another TLR 
family member, TLR2, in the brain following LPS challenge as compared to intact
females (Soucy et al. 2005).  As such, the reduced expression of critical molecules used 
in the recognition of LPS, provides a potential mechanism underlying diminished in vivo 
cytokine responses following endotoxin administration in gonadectomized females.  
Furthermore, these data suggest that physiological levels of estrogens augment innate 
immune pattern recognition receptor expression on this important sentinel immune cell 
type. 
We have previously demonstrated that acute in vitro application of exogenous 
testosterone can reduce both the cell surface and total cellular expression of TLR4 in 
RAW 264.7 macrophage-like cells and primary macrophages derived from androgen 
depleted mice.  In this study, we have assessed the acute in vitro effects of estradiol on 
pattern recognition receptor expression on innate immune sentinel cells.  We report that 
this female reproductive hormone fails to exert demonstrable effects on TLR4 levels on 
either RAW 264.7 cells or primary macrophages.  This is consistent with previous studies
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showing that acute estriol treatment of Kupffer cells (Ikejima et al. 1998), or estradiol 
treatment of macrophage-like cell lines (Vegato et al. 2004, Vlotides et al. 2007) or LPS 
challenged human monocytes (Pioli et al. 2007), does not significantly alter TLR4 or 
CD14 expression.  The actions of endogenous in vivo estradiol on macrophage pattern 
recognition receptor expression in the absence of acute effects in vitro suggest either that 
this hormone exerts delayed and sustained changes, such as those that may be envisaged 
to occur via genomic effects, or alternatively, occur as a consequence of an as yet 
undetermined intermediary effect in vivo.  Such indirect secondary effects may include 
estrogen influences on macrophage progenitor cells during hematopoiesis, or effects on 
other cell types that could in turn alter macrophage function.   
The decreased level of pattern recognition receptors for LPS in ovariectomized 
mice implies an ability of estrogens to augment the expression of these molecules.  To 
further test this hypothesis, we have assessed the effects of exogenous estradiol 
replacement on the level of expression of innate receptors for LPS.  We demonstrated 
that supra-physiological levels of estradiol following hormone replacement resulted in 
markedly higher sera levels of LBP and cell surface TLR4 and CD14 expression on 
macrophages that were associated with greater inflammatory cytokine secretion and 
dramatically higher endotoxin susceptibility.  These findings concur with previous 
studies showing that in vivo administration of estriol elevates expression of mRNA 
encoding CD14 and LBP in Kupffer cells, and that this effect corresponds with increased 
LPS-associated mortality in rats (Ikejima et al. 1998).   
While estradiol treatment resulted in increased TNF-α secretion and greater 
susceptibility to endotoxin, it did not result in significantly higher sera levels of the anti-
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inflammatory cytokine, IL-10.  Since IL-10 provides protection against sepsis (Londono 
et al. 2008, Emmanuilidis et al. 2001, van der Poll et al. 1995), lower levels of IL-10 
secretion would be expected to correlate with increased susceptibility to endotoxi  
challenge.  Consistent with this notion, pregnant mice which have high circulating 
estrogen levels demonstrate increased TNF-α expression, suppressed IL-10 levels, and 
increased mortality following LPS challenge (Vizi et al. 2001).   
Our findings indicate that estradiol treatment alters cell-surface expression of 
TLR4 but not total protein levels of this pattern recognition receptor.  This is consistent 
with previous studies that fail to detect changes in cellular TLR4 levels in whole cell 
protein isolates from peritoneal macrophages after chronic in vivo estradiol treatment 
(Calippe et al. 2008).  As such, it appears that estradiol does not alter production of TLR4 
at the protein level, but rather, affects trafficking of this receptor to the cell surface by an 
as yet unknown mechanism.   
It is interesting to note that macrophages isolated from animals that received 
replacement of both estradiol and progesterone demonstrated higher total LPS binding 
capacity than those that received estradiol alone without significantly different levels of 
TLR4 or CD14 expression.  As such, we suggest that progesterone in concert with high 
levels of estradiol may be capable of augmenting LPS binding in an as yet undetermin d 
manner. 
In general, estrogens have been considered to be “immunoprotective.”  However, 
this term fails to delineate whether estrogens act as immunoenhancers to combat bacterial 
infection, or are immunosuppressors and protect against the overactive and damaging 
immune response associated with sepsis.  The present study sheds light on this paradox 
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by showing that the effects of estrogens have to be considered in the context of both 
duration and level of exposure.  At physiological levels seen during the menstrual cycle, 
we suggest that estrogens are protective and contribute to a more robust immune respo se 
to bacterial endotoxin challenge compared to their ovariectomized counterparts.  
However, such immune responses do not render these mice more susceptible to endotoxic 
shock, perhaps due to a concurrent increase in anti-inflammatory cytokine levels.  In 
contrast, animals that have supra-physiological levels of estrogens demonstrate sensitized 
innate immune cells resulting in a more rapid and elevated inflammatory response 
following endotoxin challenge and hence greater sepsis severity.  Such a hypothesis is 
supported by recent studies in human patients showing that the probability of septic 
shock mortality is lowest when sera estrogen levels are within the normal physiological 
range but is significantly higher in non-surviving sepsis patients, regardless of sex 
(Dossett et al. 2009, May et al. 2008).
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4.4  Figures 
 
 
FIGURE 8:  Removal of endogenous estrogen reduces circulating levels of cytokines 
resulting from in vivo endotoxin challenge.  Mice were sham ovariectomized (SHAM: n 
= 6) or ovariectomized (OVX: n = 7) and received an i.p. challenge with LPS (5 mg/kg).  
At 20 hrs post challenge, sera was isolated and assayed for the presence of IL-6 (Panel 
A), TNF-α (Panel B), or IL-10 (Panel D) by specific capture ELISA.  Panel C shows 
severity of endotoxic shock assessed according to appearance and behavior and is 
reported as a severity score for each animal in the three treatment groups.  Severity was 
scored from 1 (no detectable behavioral differences) to 5 (moribund).  Asterisk indicates 






FIGURE 9:  Removal of endogenous estrogen decreases expression of key molecules 
necessary for the innate immune recognition of LPS.  Mice were sham ovariectomized 
(SHAM) or ovariectomized (OVX) five weeks prior to sera collection and isolation of 
peritoneal monocytes/macrophages.  Sera levels of LBP were assessed by p cific 
capture ELISA (Panel A: SHAM n = 8, OVX n = 7).  Total LPS binding (Panel B: 
SHAM n = 7, OVX n = 8), and cell surface TLR4 (Panel C: SHAM n = 11, OVX n = 12) 
and CD14 (Panel D: SHAM n = 7, OVX n = 8) expression on isolated macrophages was 
determined by flow cytometry.  Data is shown as the average fluorescence intensity (as 








FIGURE 10:  Acute in vitro exposure to exogenous estradiol fails to augment cell surface 
TLR4 expression on a macrophage-like cell line and primary macrophages.  Panel A: 
RAW 264.7 cells were untreated or exposed to estradiol (E2: 1 X 10
-10 M or 1 X 10-8 M) 
for 24 hours prior to analysis of cell surface TLR4 expression by flow cytometry (n = 
18).  Panel B: peritoneal macrophages derived from sham ovariectomized (SHAM) or 
ovariectomized (OVX) mice (n = 8 animals in each group) were untreated or exposed to 
estradiol (E2: 1 X 10
-10 M or 1 X 10-8 M) for 24 hours prior to analysis of cell surface 
TLR4 expression by flow cytometry.  Data is shown as the average fluorescence int sity 
(as geometric means) for each group.  Asterisk indicates a significant difference between 






FIGURE 11:  Administration of high levels of exogenous estradiol renders females ore 
susceptible to endotoxic shock.  Mice were sham ovariectomized (SHAM: n = 15), 
ovariectomized (OVX: n = 15), ovariectomized and received exogenous progesterone 
replacement (OVX+P4: n = 7), ovariectomized and received exogenous estradiol 
replacement (OVX+E2: n = 15), and ovariectomized and received exogenous estradiol 
and progesterone replacement (OVX+E2 P4: n = 7), for five weeks prior to LPS 
challenge (5 mg/kg i.p.).  At 8 hrs post-challenge, sera was isolated and assayed for the 
presence of TNF-α (Panel A) by specific capture ELISA.  The severity of endotoxic 
shock was assessed according to appearance and behavior and is reported as a severity 
score for each animal in the three treatment groups (Panel B).  Severity was scored from 
1 (no detectable behavioral differences) to 5 (moribund).  Asterisk indicates significant 
difference from sham ovariectomized animals, pound symbol indicates significant 
difference from ovariectomized animals that did not receive estrogen replacement, and 
plus symbol indicates significant difference between progesterone treated animals in the 
absence or presence of estradiol co-treatment.  All data was analyzed statistically by one-










FIGURE 12:  Administration of exogenous 
estradiol elevates cell surface expression of 
pattern recognition receptors for LPS on murine 
macrophages.  Mice were sham ovariectomized 
(SHAM), ovariectomized (OVX), or 
ovariectomized with estradiol (OVX+E2) or 
progesterone (OVX+P4) replacement, or 
received replacement of both hormones 
(OVX+E2+P4), prior to sera collection and 
isolation of peritoneal monocytes/macrophages.  
Sera levels of LBP were assessed by specific 
capture ELISA (Panel A; n = 3-8).  Total LPS 
binding (Panel B; n = 4-8), and cell surface 
CD14 (Panel C; n = 4-8) and TLR4 (Panel D; n 
= 7-12) expression on isolated macrophages was 
determined by flow cytometry.  In Panel E, 
peritoneal macrophages were permeabilized and 
total cellular content of TLR4 was assessed by 
flow cytometry (n = 4-8).  Data is shown as the 
average fluorescence intensity (as geometric 
means) for each group.  Asterisk indicates 
significant difference from sham ovariectomized 
animals, pound symbol indicates significant 
difference from ovariectomized animals, double 
dagger indicates significant difference between 
estradiol treated animals in the absence or 
presence of progesterone co-treatment, and plus 
symbol indicates significant difference between 
progesterone treated animals in the absence or 
presence of estradiol co-treatment.  All data was 
analyzed statistically by one-way ANOVA with 








CHAPTER FIVE: LONG-TERM BIPHASIC EFFECTS OF ESTROGEN EXPOSURE 




Evidence is accumulating that a sexual dimorphism exists in susceptibility o 
infectious disease.  In general, females generate more robust and potentially protective 
humoral and cell-mediated immune responses following antigenic challenge than their 
male counterparts.  This difference in immune responses has generally been assumed to 
be a consequence of the actions of reproductive hormones. Androgens have been shown 
to have suppressive effects on immune functions following trauma or trauma-hemorrage 
and subsequent sepsis (as reviewed in Marriott and Huet-Hudson 2006).  The role of 
estrogens, however, appears to be more complex.  Numerous studies have shown that 
estrogens augment immune responses and have been demonstrated to increase resistanc
to infection.  For example, estrogens have been found to be protective with treatment 
resulting in increased resistance to streptococcal infections (Nicol et al. 1964).  However, 
some groups have shown that estrogens can exacerbate the symptoms of microbial 
challenge.  Estrogen treated rodents exhibit greater mortality following gonococcal 
infection (Kita et al. 1985) or endotoxin challenge (Ikejima et al. 1998) than untreated 
animals.  As such, the mechanisms by which estrogens can exert immunoprotective 
effects continue to be debated. 
Reproductive hormones have been found to modulate the immune responsiveness 
of macrophages.  Our lab has shown that testosterone suppresses the expression of a key 
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microbial pattern recognition receptor TLR4, consistent with the immunosuppressive 
actions of testosterone.  Furthermore, we have recently discovered that the presence of 
high levels of estradiol in vivo increases cell-surface TLR4 expression on macroph ges, 
while 24 hours in vitro exposure to this female reproductive hormone fails to elicit such 
effects.  However, the mechanism by which estradiol augments TLR4 expression rmai s 
unclear.   
In this study, we have addressed the hypothesis that estradiol increases TLR4 
expression during macrophage development and maturation.  We show that bone 
marrow-derived macrophages isolated from ovariectomized animals that received high 
dose estradiol treatment in vivo have significantly less cell surface TLR4 expression than 
those derived from sham treated mice or untreated gonadectomized animals following 
short-term culture.  However, longer-term culture of these cells resulted in an apparent 
reversal of this pattern with restoration of TLR4 expression on bone marrow-derived 
macrophages isolated from estradiol treated animals and reduction in the expression of 
this pattern recognition receptor on cells from untreated gonadectomized mic  in a 
manner that is consistent with our previous observations in acutely isolated murine
peritoneal macrophages.   
 
5.2 Results 
To begin to examine the effects of estrogen on bone marrow-derived 
macrophages, myeloid precursors were isolated from the bone marrow of ovariect miz d 
or sham ovariectomized mice or animals that were ovariectomized and received implants 
of estradiol.  Adherent myeloid precursors were cultured and induced to differentate i o 
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CD11b+ cells as confirmed by staining with a fluorescent antibody against CD11b and 
analysis by flow cytometry.  Bone marrow-derived macrophages were stained for TLR4 
and examined via flow cytometry.  As shown in Figure 13A, bone marrow-derived 
macrophages isolated from ovariectomized animals receiving high levels of estrogen 
replacement had significantly lower expression of cell-surface TLR4 expression 
following eight days in culture (n = 10-23 per group, p < 0.05, ANOVA) than either 
macrophages obtained from intact females or from ovariectomized mice.  To determin  
whether the reduction in cell-surface TLR4 expression was due to decreased totl protein, 
we have assessed the relative TLR4 protein content in permeabilized cells by flow 
cytometry.  As shown in Figure 13B, total TLR4 expression is not significantly ltered 
due to the presence or absence of in vivo estrogen during culture of bone marrow-derived 
macrophages (n = 10-15).   
 To determine the long term effects of estrogen on myeloid precursors, bone 
marrow-derived macrophages were co-cultured with varying doses of estradiol and 
assayed for cell surface TLR4 expression following long-term (sixteen days) exposure.  
As seen in Figure 14, neither low physiological dose (10-10M estradiol) nor high 
physiological dose (10-8M estradiol) altered cell surface TLR4 expression on bone 
marrow-derived macrophages from ovariectomized females, intact females, or 
ovariectomized mice that received estradiol implants (n = 4).  However, following sixteen 
days in culture, bone marrow-derived macrophages from ovariectomized mice express 
significantly lower levels of cell surface TLR4 than cells from their sham operated 
counterparts (Figure 15).  Furthermore, we found that bone marrow-derived macrophages 
from ovariectomized mice receiving high doses of in vivo estradiol express significantly 
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higher levels of cell surface TLR4 than cells from either of the other two groups (Figure 
15), contrary to what is seen following short-term (eight days) culture.   
  
5.3 Conclusions 
Numerous studies have shown that estrogens augment immune responses and 
have been demonstrated to increase resistance to infection.  For example, estrogns have 
been found to be protective with exposure resulting in increased resistance to 
streptococcal infections (Nicol et al. 1964).  However, the mechanisms by which 
estrogens can exert immunoprotective effects continue to be debated.  Previous studies in 
our lab have shown that the absence of endogenous estrogens results in a significant 
decrease in cell surface, but not total, TLR4 expression on peritoneal macrophages, while 
supra-physiological levels of exogenous estradiol replacement elicits a significant 
increase in cell surface TLR4 on these cells above what is seen in cells derived from 
normal cycling females.  As these effects are seen only in vivo and not when 
macrophages are treated with estradiol in vitro for 24 hours, one hypothesis is that 
estradiol requires long-term exposure to exert its effects on cell surface TLR4 expression, 
as might be envisaged to occur during macrophage development.    
In this present study, we demonstrate that CD11b+ bone marrow-derived 
macrophages from ovariectomized animals receiving estradiol replacement xhibi
decreased expression of cell-surface TLR4 following 8 days in culture.  This reduction is 
approximately 20% lower than TLR4 levels on cells derived from intact and 
ovariectomized animals.  These results are not consistent with our previous studies 
showing in vivo estrogen exposure elevates cell-surface expression of TLR4 on 
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peritoneal macrophages.  Importantly, bone marrow-derived macrophages from 
ovariectomized animals receiving estradiol replacement did not exhibit changes in total 
protein levels of TLR4 as compared cells derived from their ovariectomized or intact 
counterparts.  As our previous studies also found no difference in total macrophage TLR4 
protein expression, this indicates that, despite conflicting effects of estradiol on cell 
surface TLR4 expression, in vivo estradiol replacement does not affect the total cellul r
production of TLR4 protein.  Other groups have also failed to detect differences in total 
cellular TLR4 protein levels following in vivo exposure to estrogens (Ikejima et al. 1998, 
Calippe et al. 2008), indicating that estradiol exposure exerts its effects only on the 
proportion of TLR4 on the surface of macrophages by an as of yet undetermined manner. 
We show that long-term two week culture of myeloid precursors resulted in an 
apparent reversal of the pattern shown following one week of culture.  Bone marrow-
derived macrophages isolated from estradiol treated animals exhibit restored levels of 
cell-surface TLR4 that are significantly higher than levels observed from intact females.  
Furthermore, cells isolated from ovariectomized mice exhibited significatly lower levels 
of cell-surface TLR4 than cells isolated from either intact of estradiol treated animals.  
This finding is consistent with our previous observations of cell-surface TLR4 expression 
from peritoneal macrophages.  Interestingly, in vitro treatment of bone-marrow derived 
cells with varying doses of estradiol during this two week period failed to mimic these 
effects.  The temporal pattern shift of TLR4 expression of bone marrow-derived 
macrophage occurred in the absence of any apparent stimulus other than long-term 
culture and development of cells.  These findings suggest that estradiol may exert effects 
in vivo prior to macrophage maturation. 
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Taken together, our previous studies have shown that in vivo exposure to estradiol 
elevates cell surface expression of a critical microbial pattern recognition receptor on a 
key sentinel immune cell type.  However, these studies demonstrate that long term in 
vitro treatment of estradiol during macrophage development fails to mimic such effe ts.  
Importantly, the present study shows that while myeloid precursors derived from animals 
with supra-physiological levels of estradiol initially have lower cell-surface TLR4 
expression, bone marrow-derived macrophages from these mice exhibit significantly 
higher levels of TLR4 following two week culture, similar to that seen in mature isolated 
peritoneal macrophages.  As such, these results suggest that the in vivo effects of long-
term estradiol on TLR4 expression occur prior to macrophage development.  Supra-
physiological levels of estradiol in vivo can exert biphasic and sustained effects on cell-
surface TLR4 expression during maturation of this key immune sentinel cell. 
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FIGURE 13:  Supra-physiological levels of in vivo estradiol decreases cell urface TLR4 
expression but not total TLR4 protein in bone marrow-derived macrophages after 8 days 
in culture.  Bone marrow cells were isolated from ovariectomized (OVX) or sham 
ovariectomized (SHAM) mice or animals that were ovariectomized and received implants 
of estradiol (OVX+E2) and induced to differentiate into CD11b+ cells.  Cells were
analyzed for TLR4 expression by flow cytometry.  Cell surface TLR4 expression (panel 
A) and total TLR4 protein (panel B) are shown for bone marrow-derived macrophages 
after 4-8 days in culture (N = 10-23).  * indicates significant difference from cells derived 
from sham ovariectomized animals, and # indicates significant difference from cells 







FIGURE 14:  Long-term (16 day) in vitro estradiol treatment fails to elicit changes in 
TLR4 expression on bone marrow-derived macrophages.  Bone marrow cells were 
isolated from sham ovariectomized (SHAM), ovariectomized (OVX), or ovariectomized 
with estrogen replacement (OVX+E2) and induced to differentiate into CD11b+ cells. 
Cells were exposed to estradiol (10-10M E2 and 10-8M E2) for two weeks, and then 








FIGURE 15:  Supra-physiological levels of in vivo estradiol exert sustained effects on 
cell-surface TLR4 expression of macrophages during 16 days of culture.  Bone marrow 
cells were isolated from sham ovariectomized (SHAM), ovariectomized (OVX), or 
ovariectomized with estrogen replacement (OVX+E2) and induced to differentiate i to 
CD11b+ cells.  Cells were analyzed for TLR4 expression by flow cytometry after 16 days 
in culture (data pooled from Figure 14).  * indicates significant difference from cells 
derived from sham ovariectomized animals, and # indicates significant difference from 








CHAPTER SIX:  GPR30/GPER-1 MEDIATES RAPID DECREASES IN TLR4 




It has become increasingly apparent that sexual dimorphism exists in 
susceptibility to infectious diseases (as reviewed in Marriott and Huet-dson 2006).  In 
general, females generate more robust and potentially protective immune respons s 
following antigenic challenge than their male counterparts.  Furthermore, this sexual 
dimorphism extends to bacterial sepsis, where male patients exhibit 70% mortality while 
it is lethal in only 26% of females (Schroder et al. 1998).  Such differences in immunity 
have generally been assumed to be a consequence of the actions of reproductive 
hormones.  Consistent with such a hypothesis, estrogens have been found to promote 
increased resistance to streptococcal infections (Nicol et al. 1964) while we have shown 
that androgens suppress acute host immune responses to bacterial endotoxin challenge.  
However, ascribing precise roles in immune responses to estrogens has proven 
challenging as the literature is rife with apparently contradictory observations 
demonstrating that estrogens can both augment and limit host immunity. 
While the ability of estrogens to evoke opposite effects on immune function may 
depend on the level of these sex hormones and/or the acute or chronic nature of the host 
response, an alternative explanation may lie in the expression of both classical nd non-
classical estrogen receptors by immune cell types.  G protein-coupled receptor 30 
(GPR30; also known as G protein-linked estrogen receptor 1) is a membrane-bound 
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molecule that has been found to mediate several rapid cellular effects of estrogen 
including the activation of the MAP kinase signaling cascade, cAMP activation, nd 
intracellular calcium mobilization (Filardo et al. 2002, Filardo et al. 2007).  As such, it 
has been suggested that GPR30 is a non-classical receptor for estrogen although this 
notion remains controversial (as discussed in Langer et al. 2010).  GPR30 has been found 
to be expressed by a wide variety of tissues and cell types (as reviewed in Pross itz et al. 
2008) including those that exhibit immune functions (Kanda and Wantanabe 2003, 
Blasko et al. 2009).  It is therefore conceivable that estrogen could elicit rapid changes in 
the immune responses of these cells via this membrane-bound receptor. 
Cellular responses to gram-negative bacteria-derived lipopolysaccharide (LPS) 
are mediated by Toll-like receptor 4 (TLR4).  Ligation of TLR4 activates transcription 
factors that initiate the production of inflammatory cytokines and chemokines.  These
molecules promote protective immune responses but their over-production leads to 
systemic inflammatory responses and the catastrophic drop in blood pressure associated 
with bacterial septic shock (as reviewed in Akira 2006, Palsson-McDermott and O’Neill 
2004).  We have previously demonstrated the ability of super-physiological levels of 
17β-estradiol to significantly elevate TLR4 expression on macrophages and to increase 
susceptibility of mice to in vivo LPS challenge.  In agreement with this finding, other 
groups have shown that long term treatment of mice with estrogens increases 
inflammatory mediator production following challenge with bacteria or their products, 
and that this effect is mediated by the classical nuclear estradiol receptor, estrogen 
receptor alpha (ERα) (Soucy et al. 2005, Calippe et al. 2008).  In the present study, we 
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demonstrate that 17β-estradiol can conversely elicit rapid decreases in cell surface TLR4 
expression on macrophages and show that such effects are mediated by GPR30. 
 
6.2 Results 
To begin to determine the acute direct effects of estrogens on macrophages, we 
have exposed RAW 264.7 macrophage-like cells cultured in charcoal-stripped FBS to 
minimize the effects of reproductive hormones to 17β-estradiol for various periods prior 
to analysis of cell-surface TLR4 by flow cytometry.  As shown in Figure 16A, 7β-
estradiol treatment failed to elicit significant changes in cell-surface TLR4 expression at 
24 to 72 hours following exposure.  However, cell-surface TLR4 expression on RAW 
264.7 cells was significantly decreased by approximately 20% (p < 0.05) one hour after 
17β-estradiol addition (Figure 16B). 
To begin to determine whether estrogen elicits rapid decreases in TLR4 levels on 
macrophages via a non-classical membrane receptor, we confirmed the expression of 
GPR30 in these cells.  As shown in Figure 17A, both RAW 264.7 cells and primary 
murine peritoneal macrophages constitutively express mRNA encoding GPR30 as 
determined by semi-quantitative PCR.  Importantly, we have confirmed that resting 
macrophage-like cell line and primary macrophages derived from male and femalemice 
express GPR30 protein as determined by immunoblot analysis (Figure 17B). 
To assess the role of GPR30 in acute estrogen-mediated reductions in TLR4 
expression, we have used silencing RNA to knockdown expression of this receptor in 
RAW 264.7 cells.  Cells were transfected with either siRNA directed against GPR30 or a 
negative control duplex 48 hours prior to experimentation, and we have confirmed that 
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the GPR30 specific siRNA duplex markedly attenuates GPR30 mRNA levels in RAW 
264.7 cells (Figure 18A).  We then assessed the effects of estrogen on TLR4 expression 
by RAW 264.7 cells following transfection.  As shown in Figure 18B, 17β-estradiol 
elicits a significant decrease in cell-surface TLR4 expression on cells transfected with a 
negative control duplex at 60 to 120 minutes following treatment.  Importantly, such 
treatment failed to elicit significant changes in cell-surface TLR4 expression following 
transfection with siRNA directed against GPR30 (Figure 18C). 
To further confirm that the ability of estrogens to elicit rapid decreases in TLR4 
expression on macrophages is mediated by GPR30 we have examined the effects of 
GPR30 specific agonists.  RAW 264.7 cells were acutely treated with ICI 182780, a 
compound that has been widely employed as an inhibitor of the classical nuclear estrogen 
receptors but is also thought to act as a GPR30 agonist (Thomas et al. 2005).  As shown 
in Figure 19A, ICI 182780 elicited a significant decrease cell-surface TLR4 expression at 
60 and 120 minutes following treatment, with maximal reduction of approximately 18%.  
We have also employed a second GPR30 agonist, G1, which does not bind to ERα or 
ERβ (Bologa et al. 2006).  As shown in Figure 19B, treatment of cells with G1 results in 
a significant decrease in cell-surface TLR4 expression as rapidly as 10 minutes post 
exposure with a maximal reduction at 120 minutes of approximately 27% (Figure 19B). 
We have extended our findings with this macrophage-like cell line to primary 
cells in experiments employing peritoneal macrophages isolated from male C57BL6 mice 
and we show that G1 similarly elicits a significant decrease in cell-surface TLR4 
expression on primary peritoneal macrophages within 10 minutes following treatment 
(Figure 19C).  Furthermore, we have confirmed that the ability of G1 to down-regulate 
95 
 
TLR4 expression is mediated via GPR30 using silencing RNA directed against this 
receptor.  As shown in Figure 19D, G1 induced a reduction in TLR4 expression in RAW 
264.7 cells transfected with a negative control duplex.  Importantly, this effectwas absent 
in cells transfected with siRNA directed against GPR30 (Figure 19E). 
To determine the biological significance of GPR30-mediated reductions in 
macrophage cell-surface TLR4 expression, we have assessed the effects of GPR30 
agonists on the LPS-induced immune responses of these sentinel cells.  As shown in 
Figure 20A, G1 treated RAW 264.7 cells demonstrated reduced ability to bind 
fluorescently labeled LPS as determined by flow cytometry.  Importantly, RAW 264.7 
cells acutely treated with this GPR30 agonist produced significantly lower lev ls PGE2 
(Figure 20B; approximately 46% less) at 2 hours following LPS challenge, a d the 
reduced production of the key inflammatory cytokines IL-6 (Figure 20C; approximately 
34% lower) and TNF-α (Figure 20D; approximately 12% lower) at 24 hours after 
exposure to LPS. 
 
6.3 Conclusions 
Sex-based differences in host responses to microbial pathogens have been 
proposed to result from the direct effect of reproductive hormones on immune cells that 
bear receptors for these sex steroids.  Such a hypothesis is supported by findings that the 
greatest sex dimorphisms in immune responses is seen in adults of reproductive age.  
Furthermore, recent research has shown that reproductive hormones, in particular 
testosterone and estrogen, have significant effects on immune responses.  Testosterone is 
widely accepted to be immunosuppressive and can increase susceptibility of both males 
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and females to bacterial infection.  In contrast, estrogens are suggested to be 
immunoprotective and have been found to increase resistance to both bacterial infection 
(Ohtani et al. 2007, Nicol et al. 1964, Tsuyuguchi et al. 2001) and endotoxin challenge 
(Sener et al. 2005, Erikoglu et al. 2005).  However, studies employing exogenous 
estrogen treatment have yielded conflicting results that may result in differences in 
concentrations of estrogens used or the treatment regimen.  Indeed, recent in vivo studies 
in our laboratory have shown that endogenous levels of estrogens promote robust 
immune response to LPS in mice without increasing susceptibility to endotoxin 
challenge, but long-term super-physiological doses of 17β-estradiol elevates LPS-
induced inflammatory cytokine production and dramatically increases sepsis severity.  
Finally, it has been reported that short term in vitro treatment with 17β-estradiol 
attenuates macrophage responses to LPS, while chronic in vivo estrogen exposure 
dramatically increases LPS-induced inflammatory cytokine expression, an effect that was 
mediated by ERα (Calippe et al. 2008).  To date, the mechanisms that underlie this 
apparent paradox have not been identified. 
GPR30 is a membrane bound molecule that has been shown to mediate rapid 
cellular events in a variety of cell types and has been proposed to serve as a non-cl ssical 
estrogen receptor (as reviewed in Prossnitz et al. 2008).  It should be noted that while 
several groups have provided experimental evidence that GPR30 serves as a novel 
estrogen receptor, others suggest that this molecule functions to modulate classical 
estrogen receptor-mediated effects (Levin 2009).  Defining the role of GPR30 has been 
further complicated by the current absence of reliable GPR30 deficient mouse odels (as 
discussed in Langer et al. 2010).  This putative membrane-bound estrogen receptor is 
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expressed by a variety of cell types including those that have immune functions.  GPR30 
has been reported in myeloid cells including the monocytic cell line THP-1, human 
peripheral blood monocytes, and rat microglia (Kanda and Wantanabe 2003, Blasko et al. 
2009).  In the present study, we have demonstrated that both primary murine peritoneal 
macrophages and a macrophage-like cell line constitutively express this molecule at the 
level of both mRNA and protein expression.  As such, the presence of this molecule in 
macrophages could represent a means by which female sex steroids can rapidly alter 
immune cell function. 
We have demonstrated that short term in vitro treatment with 17β-estradiol elicits 
rapid decreases in TLR4 expression on macrophages and this could explain the finding 
by Calippe and co-workers (2008) that such treatment attenuates macrophage responses 
to LPS.  Importantly, we show that two GPR30 specific agonists that do not employ 
classical nuclear estrogen receptors can mimic such effects in both RAW 264.7 cells and 
primary macrophages.  Furthermore, we have established that the rapid effects of 17β-
estradiol on TLR4 expression are due to the presence of GPR30 and confirmed that the 
actions of G1 are similarly mediated by this putative estrogen receptor by employing 
siRNA techniques to knockdown GPR30 expression in a transfectable macrophage-like 
cell line.  Taken together, these experiments clearly demonstrate that GPR30 mediates the 
ability of estrogens to rapidly down-regulate the expression of a critical mi robial pattern 
recognition receptor on this sentinel immune cell. 
Finally, we have established the functional significance of GPR30-mediated 
reductions in cell surface TLR4 expression on macrophages by demonstrating that these 
cells have a decreased ability to respond to bacterial endotoxin challenge.  We show that 
98 
 
pre-treatment of macrophage-like cells with a GPR30 specific agonist significantly 
reduces LPS binding to these cells and inhibits LPS-induced production of an 
inflammatory prostanoid and key inflammatory cytokines.  Again, these findings could
help to explain the previous report that two-hour 17β-estradiol treatment significantly 
reduces LPS-mediated increases in inflammatory mediator mRNA expression in murine 
peritoneal macrophages (Calippe et al. 2008).  Furthermore, the present demonstration 
that GPR30 can mediate rapid changes in innate immune receptor expression by myeloid
cells appears to be consistent with the recent demonstration that exposure of human blood 
mononuclear cells to G1 for one hour is sufficient to reduce TNF-α and IL-6 production 
initiated by a ligand for the pattern recognition receptor(s) TLR3 and/or MDA5 (Blasko 
et al. 2009). 
While estrogens are generally considered to be “immunoprotective", this term 
fails to distinguish between their ability enhance host immune defenses to combat 
infection and their ability to suppress such responses to protect against potentially l th  
inflammation.  The balance between the immunosuppressive and immunoenhancing 
activities of reproductive sex steroids appears to be influenced by both the duration and 
level of exposure of immune cells to them.  The present study may shed light on this 
issue by showing the functional presence of a membrane-bound molecule on 
macrophages that has been suggested to function as a non-classical estrogen receptor, and 
the demonstration that this molecule can mediate rapid cellular effects that modulate this 
cell's sensitivity to microbial motifs.  As such, estrogens may be able to reduce the 
devastating inflammation associated with acute overactive host responses such a  eptic 
shock without compromising long-term defense against infectious organisms.  Finally, 
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the present demonstration that G1 is effective in limiting inflammatory responses, in 
concert with the previous finding that this GPR30 ligand can reduce disease severity of a 
mouse model of CNS inflammation (Blasko et al. 2009), raises the exciting possibility 







FIGURE 16:  Estrogens decrease macrophage cell-surface TLR4 expression following 
short but not long term in vitro exposure.  RAW 264.7 cells were untreated (ctrl) or 
exposed to long-term (1-3 days; Panel A, n = 6-18) or short-term (10-120 minutes; Pan l 
B, n = 12) 17β-estradiol (E2; 1 x 10-6 M) treatment and then assayed for cell-surface 
TLR4 expression.  Asterisk indicates a statistically significant difference from untreated 











FIGURE 17:  GPR30, a putative membrane-bound estrogen receptor, is expressed by 
macrophages.  Panel A: primary murine macrophages and the RAW 264.7 macrophage-
like cell line express mRNA encoding GPR30 as assessed by semi-quantitative RT-PCR.  
Panel B: primary murine macrophages and RAW 264.7 cells express protein for GPR30 
as assessed by Western blot analysis.  Positive controls for mRNA encoding GPR30
(uterus) and GPR30 protein expression (brain) are shown (+).  Results shown are 








FIGURE 18:  Estrogen-mediated reductions in TLR4 expression are abolished following 
GPR30 knockdown.  RAW 264.7 cells were transfected with either siRNA directed 
against GPR30 or a negative control duplex.  Panel A: GPR30 mRNA expression was 
assessed by RT-PCR in cells transfected with the negative control duplex (ctrl) and cells 
in which GPR30 was knocked down (siRNA).  Panel B shows cell-surface TLR4 
expression of untreated cells (ctrl), or following 17β-estradiol (E2; 1 x 10-6 M) treatment 
of cells transfected with a negative control duplex (n = 6).  Panel C shows cell-surface 
TLR4 expression of untreated cells (ctrl), or following 17β-estradiol (E2; 1 x 10-6 M) 
treatment of cells transfected with siRNA directed against GPR30 (n = 6).  Asterisk 












FIGURE 19:  GPR30 agonists decrease 
cell-surface TLR4 expression on 
macrophages.  Panel A:  RAW 264.7 
cells were untreated (ctrl) or treated with 
ICI 182780 (ICI; 1 x 10-5 M) and then 
assayed for cell-surface TLR4 
expression (n = 6).  Panel B: RAW 
264.7 cells were treated with G1 (1 x 10-
6 M) and then assayed for cell-surface 
TLR4 expression (n = 12).  Panel C: 
primary peritoneal macrophages were 
treated with G1 (1 x 10-7 M) and then 
assayed for cell-surface TLR4 
expression (n = 6).  Panel D shows the 
effect of transfection of RAW 264.7 
cells with siRNA directed against 
GPR30 on G1-mediated reductions in 
TLR4 expression (n = 4).  Panel E 
shows the absence of effects of 
transfection of RAW 264.7 cells with 
negative control duplex on G1-mediated 
reductions in TLR4 expression (n = 6).  
Asterisk indicates significant difference 













FIGURE 20:  GPR30 ligation attenuates endotoxin-induced macrophage immune 
responses.  Panel A: RAW 264.7 cells were untreated (ctrl) or treated with G1 for30 
minutes and then assayed for their ability to bind fluorescently labeled LPS by flow 
cytometry (n = 4).  Panel B: RAW 264.7 cells were treated with G1 for 2 hours prior to 
the addition of LPS and PGE2 production was assessed at 2 hours following endotoxin 
challenge (n = 5).  RAW 264.7 cells were treated with G1 for 2 hours prior to exposure to 
LPS and IL-6 (Panel C) and TNF-α (Panel D) content was assessed at 24 hours following 
endotoxin challenge (n = 12).  Asterisk indicates significant difference from control cells 










CHAPTER SEVEN:  SUMMARY AND CONCLUSIONS 
 
 
7.1  Reproductive hormones alter pattern recognition receptor expression on 
macrophages 
Sex-based differences in innate immune responses to bacterial infection are 
evident in human patients and animal models of disease.  Females are less susceptible to 
the development of bacterial infections and subsequent bacteremia and/or sepsis while 
males exhibit a greater incidence of such infections and are more likely to devel p fatal 
sequelae.  While the precise effects and mechanisms of action remain to be determined, it 
is apparent that male and female reproductive hormones can have direct effects on the 
expression and function of key bacterial pattern recognition receptors on innate immune 
cells.  Changes in the expression of these receptors are likely to have profound effects on 
the production of the inflammatory mediators responsible for the lethal nature of septic 
shock (as shown in Figure 1) and may underlie the observed sexual dimorphism 
demonstrated in immune responses to bacterial endotoxins.   
 Androgens, such as testosterone, are widely accepted as immunosuppressive.  We 
have shown that testosterone decreases TLR4 expression on macrophages, both in vitro 
and in vivo.  This implies a direct effect of testosterone to suppress the ability of 
macrophages to recognize and respond to bacterial LPS.  Indeed, testosterone decreases 
both total and cell-surface TLR4 expression, indicating that this reproductive hormone 
either alters recycling and/or gene expression of TLR4, and that this decreas  is not 
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simply due to receptor internalization.  Importantly, testosterone also suppresses 
inflammatory mediator production from macrophages following LPS challenge.  As such, 
the evidence that testosterone can modulate the expression of a key receptor for LPS may 
represent an important mechanism underlying the immunosuppressive effects of this 
androgen. 
Estrogens, such as estradiol, are generally considered to be immunoprotective.  
However, this term fails to distinguish between their ability enhance host immune 
defenses to combat infection and their ability to suppress such responses to protect 
against the overactive and damaging inflammatory immune response associated with 
sepsis.  The balance between the immunosuppressive and immunoenhancing activities of 
estrogens appears to be influenced by both the duration and level of exposure to immune 
cells. 
We have shown that estradiol significantly increases cell-surface TLR4 
expression on macrophages, enhancing the ability of these cells to recognize and respo  
to LPS.  At physiological levels seen during the menstrual cycle, we suggest that 
estrogens are protective and contribute to a more robust immune response to bacterial 
endotoxin challenge.  However, such immune responses do not render intact female mice 
more susceptible to endotoxic shock, perhaps due to a concurrent increase in 
immunosuppressive responses.  In contrast, animals that have supra-physiological levels 
of estrogens demonstrate sensitized innate immune cells resulting in a more rapid and 
elevated inflammatory response following endotoxin challenge and hence greatr sepsis 
severity.  This notion is supported by a study of peripheral monocytes from pre-
menopausal women with normal menstrual cycles.  Interestingly, the activity of 
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monocytes correlated with the menstrual cycle.  As sera estradiol levels increased, 
cytokine production from monocytes also increased.  Likewise, when sera estradiol levels 
decreased over time during a normal cycle, so did cytokine levels (Verthelyi and Klinman 
2000).  
Estradiol treatment in vivo increased cell-surface TLR4 expression, but not total 
protein levels, indicating that estradiol is somehow involved in trafficking of this receptor 
to the cell surface.  As we found that estradiol only augmented TLR4 expression in vivo 
and not following short-term in vitro treatment, we then analyzed the effects of long-term 
culture of bone marrow-derived macrophages with estradiol.  We have shown that culture 
with estradiol for two weeks fails to alter cell-surface TLR4 expression.  However, 
macrophages derived from animals receiving long-term supra-physiological levels of 
exogenous estradiol over time develop higher levels of TLR4 compared to cells from 
intact females, in the absence of any other known stimulus.  This indicates that the long-
term effects of estradiol that increase cell-surface TLR4 expression may be indirect.  
Furthermore, these effects occur prior to macrophage development and exert sustained 
effects during maturation of this key immune sentinel cell.  The long lasting sustained 
effects of estradiol could be due to the well known epigenetic effects of this reproductive 
hormone and environmental estrogens (Prins et al. 2008, McLachlan et al. 2006, 
Guerrero-Bosangna et al. 2005).  Verification of such a hypothesis would require further
study. 
Finally, we have shown that acute in vitro treatment of macrophages with 
estradiol reduces TLR4 expression, an opposite effect to what is seen due to long-term 
exposure to estradiol in vivo.  The roles of estrogens in modulating immune responses are 
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clearly complex, but we have shed some light on this issue by showing the functional 
presence of the non-classical estrogen receptor GPR30, and the demonstration that this 
molecule can mediate rapid cellular effects that modulate macrophages’ sensitivity to 
microbial motifs.  The rapid decrease in sensitivity to LPS would be especially important 
during the onset of sepsis.  While chronic infections may last for months or even years, 
the development of sepsis occurs much more quickly, within one to a few days post 
exposure to endotoxin.  The potential for estradiol to limit overactive host immune 
responses to LPS could provide a mechanism by which pre-menopausal women are less 
susceptible to the development of sepsis than men.  Furthermore, the demonstration that 
the GPR30 specific agonist G1 is effective in limiting inflammatory responses raises the 
possibility that such agonists may have therapeutic potential. 
In summary, we have shown the immunosuppressive effects of testosterone are 
fairly simple compared to the dichotomous effects of estradiol.  Testosterone decreases 
TLR4 expression, and suppresses subsequent inflammatory responses and susceptibility 
to sepsis.  The effects of estrogen, however, are contingent on the dosage, timing, and 
manner of treatment.  As such, estrogens may be able to reduce the devastating 
inflammation associated with acute overactive host responses such as septic shock 
without compromising long-term defense against infectious organisms.  In this way, the 
effects of estradiol resemble a balancing seesaw, in which two extremes can push the host 
immune response off balance.  Supra-physiological long-term estradiol can exacerbate 
the symptoms of sepsis by increasing damaging inflammatory responses.  However, too 
little estradiol can limit immune responses and compromise the ability of the host to 
respond to pathogens.  Such a hypothesis is supported by recent studies in human patients 
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showing that the probability of septic shock mortality is lowest when sera estrog n levels 
are within the normal physiological range but is significantly higher in non-surviving 
sepsis patients, regardless of sex (Dossett et al. 2009, May et al. 2008).  We suggest that 
the perfect balance of physiological levels of estradiol, as seen in normal cycling females, 
balancing the seesaw at the point where females exhibit greater resistance to both 
infectious challenge and the development of sepsis.  As such, cycling levels of estradiol 
in the physiological range has earned the term “immunoprotective.” 
 
7.2 Potential for future studies 
Sex steroid hormones can elicit demonstrable changes in the expression and 
function of microbial pattern recognition receptors and can significantly alter the 
production of soluble immune mediators responsible for lethal septic shock.  However, 
linking these effects to the sex differences in susceptibility to bacteril infection and 
sepsis severity remains challenging as the two ideas are in some cases seemingly 
paradoxical.  For example, testosterone suppresses the production of inflammatory 
mediators and decreases susceptibility to sepsis, yet men exhibit greater severity and 
higher mortality associated with sepsis than do women.  While the precise mechanisms 
remain to be determined, we propose a scenario, summarized in Figure 21, in which male 
sepsis patients exhibit reduced levels of immunosuppressive testosterone due to inhibiti n 
of testosterone production by LPS (Reddy et al. 2006), and highly elevated levels of 
estrogen, perhaps due to increased activity of aromatase from LPS and/or inflammatory 
cytokines (Schmidt et al. 2000, Singh et al. 1997).  This, at least in males, leads to an 
excessive and damaging systemic immune response.  Together, reduced testosterone and 
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elevated estrogen levels in males would facilitate expression of TLR4, CD14, and LBP 
rendering sentinel immune cells more sensitive to bacterial LPS and leading to markedly 
elevated levels of soluble inflammatory mediators thereby precipitating septic shock.  
These effects are on top of already increased levels of TLR4, CD14, and LBP found in 
males compared to females (Marriott et al. 2006).  Further research is required to validate 
such a hypothesis and to develop a therapeutic intervention during the development of 
sepsis to counter these effects. 
Estradiol has been proposed by a wide variety of investigators as a therapeutic 
treatment for patients suffering from trauma induced septic shock (Angele et al. 1999, 
Ghisletti et al. 2005, Hsieh et al. 2007b, Knoferl et al. 2002, Ohtani et al. 2007, Sener et 
al. 2005, Raju et al. 2008).  However, estradiol has complicating effects if dosage is too 
high or treatment too prolonged.  Also, estradiol has multiple receptors to which it can 
bind and activate a variety of cellular responses.  The recent discovery of GPR30 and its 
specific ligand G1, which does not bind to the classical nuclear estrogen receptors, has 
opened the door to specifically targeting certain estrogenic effects without nitiating 
responses from all estrogen receptors.  We demonstrated that G1 significantly decreases 
TLR4 expression within 10 minutes, and it effectively limits inflammatory responses 24 
hours after treatment, indicating it exerts sustained effects.  This is in concert with the 
previous finding that this GPR30 ligand can reduce disease severity of a mouse model of 
CNS inflammation (Blasko et al. 2009), which raises the exciting possibility tha  such 
agonists may have therapeutic potential.  As such, further research is warranted to 
investigate the ability of G1 or other GPR30 specific targets to limit immune responses in 
patients exhibiting symptoms of severe sepsis and septic shock. 
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Figure 21:  Putative mechanism by which testosterone and high levels of exogenous 
estrogen can exacerbate the symptoms of sepsis by affecting levels of TLR4. LPS 
inhibits testosterone synthesis thereby removing the inhibitory effect of testst rone on 
TLR4 expression on sentinel cells.  Elevation of estrogen levels (perhaps via a direct 
action of LPS) increases TLR4 expression.  LPS is recognized via TLR4 on these 
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